fluorouracil has been researched along with carboplatin in 564 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (2.30) | 18.7374 |
| 1990's | 151 (26.77) | 18.2507 |
| 2000's | 187 (33.16) | 29.6817 |
| 2010's | 179 (31.74) | 24.3611 |
| 2020's | 34 (6.03) | 2.80 |
| Authors | Studies |
|---|---|
| Bassermann, R; Nathrath, W; Voigt, H | 1 |
| Peters, GJ; Treskes, M; van der Vijgh, WJ; van der Wilt, CL; van Laar, JA | 1 |
| Anderson, KC; Ayash, L; Elias, AD; Hunt, M; Lynch, C; Mazanet, R; Pap, S; Schwartz, G; Tepler, I; Wheeler, C | 1 |
| Bender, HG; Michel, RT; Mitze, M; Stegmüller, M; Vering, A | 1 |
| Bauer, FP; Kehrl, W; Westhofen, M | 1 |
| Brandes, A; Fiorentino, MV | 1 |
| Baillet, F; Depondt, J; Dubreuil, C; Gehanno, P; Guerrier, B; Martin, M; Pellae Cosset, B; Peynegre, R; Peytral, C | 1 |
| Goldman, S; Kaigas, M; Svensson, C | 1 |
| Allegra, CJ; Denicoff, AM; Gupta-Burt, S; Pai, LH; Poirier, MC; Reed, E; Swain, SM; Venzon, DJ | 1 |
| Shimada, Y; Yokoyama, T | 1 |
| Gonzalez, FG; Herranz, P; Hidalgo, OF; Rebollo, J; Tangco, E; Vieitez, JM | 1 |
| Allegra, C; Jacob, J; Ozols, RF; Reed, E; Young, RC | 1 |
| Buesa, JM; Cueva, JF; De Sande, L; Esteban, E; Estrada, E; Gracia, JM; Lacave, AJ; Palacio, I | 1 |
| Bastian, G; Fournier, C; Hecquet, B; Khayat, D | 1 |
| Bauer, FP; Westhofen, M | 1 |
| Covens, A; Mazurka, J; O'Connell, G; Rusthoven, J | 1 |
| Bleier, R; Welkoborsky, HJ; Wissen-Siegert, I | 1 |
| Ensley, JF; Forastiere, AA; Hutchins, LF; Kish, JA; McClure, S; Metch, B; Schuller, DE; Triozzi, P; VonFeldt, E; Williamson, SK | 1 |
| Back, T; Damia, G; Futami, H; Gruys, ME; Keller, JR; Komschlies, KL; Longo, DL; Ruscetti, FW; Wiltrout, RH | 1 |
| Gotoda, A; Kamiyama, T; Matsuoka, S; Nagabuchi, E; Nakajima, Y; Saito, M; Uchino, J; Une, Y | 1 |
| Cappelaere, P; Chauvergne, J; Chazard, M; Fargeot, P; Meeus, L; Metz, R; Schneider, M; Vignoud, J | 1 |
| Banis, K; Daniilidis, J; Dimitriadis, A; Fountzilas, G; Kalogera-Fountzila, A; Kosmidis, P; Makrantonakis, P; Nicolaou, A; Sombolos, K; Sridhar, KS | 1 |
| Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T | 1 |
| de Graeff, A; Heintz, AP; Neijt, JP; Tjia, P; van Hoef, ME | 1 |
| Achterrath, W; Harstrick, A; Meyer, HJ; Preusser, P; Schmoll, HJ; Seeber, S; Stahl, M; Wilke, H | 1 |
| Avramidis, V; Banis, K; Beer, M; Fountzilas, G; Kalogera-Fountzila, A; Kosmidis, P; Makrantonakis, P; Sombolos, K; Sridhar, KS; Themelis, C | 1 |
| Baltzer, J; Maassen, V; Stumpfe, M | 1 |
| Jirapanuwat, S; Panichevalux, A; Sangruchi, S; Skulchan, V; Tepmongkol, P; Thanaphum, V; Thansakul, A | 1 |
| de Vries, EG; Hoekstra, HJ; Mulder, NH; Nanninga, AG; Oosterhuis, BE; Sleijfer, DT; Willemse, PH | 1 |
| Evensen, JF; Gundersen, S; Høst, H; Kaasa, S; Tausjø, J; Thorud, E; Wist, E | 1 |
| Botet, J; Casper, E; Dougherty, J; Hudis, C; Kelsen, D; Niedzwiecki, D; Rosenbluth, R; Vinciguerra, V | 1 |
| Allsopp, MA; Northcott, M; Powell, H; Sewell, GJ | 1 |
| Iwanari, O; Kitao, M; Miyako, J; Moriyama, M; Nakayama, S; Ryuko, K | 1 |
| Volling, P | 1 |
| Beauduin, M; Grégoire, V; Hamoir, M; Humblet, Y; Longueville, J; Majois, F; Remacle, FM; Rousseau, F; Salamon, E; Wambersie, A | 1 |
| Markman, M | 1 |
| Amer, MH; Hannan, MA; Hussain, SS | 1 |
| Furukawa, S; Kubota, A; Miyata, K; Mochimatsu, I; Ryo, I; Sawaki, S; Tukuda, M; Yanoma, S; Yoshida, T | 1 |
| Aroney, R; Bishop, JF; Cruickshank, D; Dalley, D; Hughes, P; Olver, IN; Woods, R | 1 |
| Achterrath, W; Rauschning, W; Schröder, M; Stennert, E; Volling, P | 1 |
| Brienza, S; Chenu, E; de Vassals, F; Eriguchi, M; Fredj, G; Kidani, Y; Mathé, G; Misset, JL; Peytavin, G; Segiguchi, M | 1 |
| Knüsli, C; Laffer, U; Obrecht, JP; Obrist, R; Ruff, P; Stoll, HR; Weber, W | 1 |
| Dodge, RK; Forastiere, AA; Goren, MP; Horowitz, ME; Kamen, BA; Pratt, CB; Viar, MJ; Wright, RK | 1 |
| al-Sarraf, M; Corbett, TH; Polin, L; Tapazoglou, E | 1 |
| Achterrath, W; Nagel, G; Rauschning, W; Schröder, M; Stennert, E; Volling, P | 1 |
| Forastiere, AA; Goren, MP; Kudla-Hatch, V; Natale, RB; Takasugi, BJ; Vogel, WC | 1 |
| Xu, B | 1 |
| Haraf, DJ; Levin, J; Malone, D; Stenson, K; Stupp, R; Vokes, EE; Weichselbaum, RR | 1 |
| Burghouts, JT; Huider, MC; Kamphuis, JT; Kateman, I; Ras, GJ; Verhagen, CA; Vreeswijk, JH | 1 |
| Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M | 1 |
| Antman, K; Ayash, L; Elias, AD; Frei, E; Mazanet, R; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C | 1 |
| Eckardt, A; Kelber, A | 1 |
| Turrisi, AT; Urba, SG | 1 |
| Baez, L; Benner, SE; Brooks, J; Dimery, IW; Earley, CL; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M; Winn, RJ | 1 |
| Dercksen, MW; Dirkson, MK; Gerritsen, WR; Pinedo, HM; Rodenhuis, S; Schaasberg, WP; Slaper-Cortenbach, IC; van der Schoot, CE; von dem Borne, AE | 1 |
| Kosmidis, P; Kyparidou, E; Lygidakis, NJ; Parissis, J; Ziras, N | 1 |
| Chan, AT; Choi, PH; Johnson, PJ; Lee, WY; Leung, SF; Leung, TW; Teo, PM; Yeo, W | 1 |
| Bizjak, L; Jernej, B; Kapitanović, S; Osmak, M | 1 |
| Hoshima, M; Koishi, K; Koyama, H; Masuyama, M; Miyata, K; Mugitani, T; Takahashi, T; Tanaka, H; Taniguchi, H | 1 |
| Eckardt, A; Kelber, A; Pytlik, C | 1 |
| Schröder, M; Volling, P | 1 |
| Brunet, J; Burgués, J; De Andrés, L; López, JJ; López-Pousa, A; Mesía, R; Tabernero, JM; Vega, M | 1 |
| Fukura, Y; Hatakeyoma, F; Kanno, M; Kikuchi, T; Nakamura, M; Oikawa, K; Saitou, K; Sawada, K; Shibuya, S; Tan, M | 1 |
| Dion, JE; Jane, JA; Jensen, ME; Larner, JM; Newman, SA; Phillips, CD | 1 |
| Carbone, A; Dal Bo, V; Francini, M; Lo Re, G; Monfardini, S; Santarossa, S; Talamini, R; Trovò, MG; Veronesi, A | 1 |
| Klostergaard, J; Leroux, ME; Tomasovic, SP | 1 |
| Ebeling, O; Eckel, HE; Heitmann, K; Volling, P; Vössing, M | 1 |
| Carstensen, J; Malmström, H; Simonsen, E | 1 |
| Blitzer, PH; Dosoretz, DE; Harwin, WN; Katin, MJ; Mangano, MM; Raymond, MG; Rubenstein, JH; Salenius, SA; Seidenstein, L; Teufel, TE | 1 |
| Allsopp, M; Collinson, MP; Copplestone, JA; Prentice, AJ; Sewell, GJ; Tyrrell, C | 1 |
| Hangai, K; Hatayama, N; Horio, K; Saito, H; Sakurai, Y; Takamura, A | 1 |
| Homma, A; Iizuka, K; Nakamaru, Y; Yonekawa, H | 1 |
| Bonadonna, G; Brambilla, C; Ferrari, L; Passoni, P | 1 |
| Depondt, J; Gehanno, P; Guerrier, B; Lelievre, G; Martin, M; Pellae-Cosset, B; Peytral, C; Schott, H | 1 |
| Hafström, L; Heath, DD; Howell, SB; Lindnér, P; Naredi, P; Shalinsky, DR | 1 |
| Bajetta, E; Biganzoli, L; Buzzoni, R; Nolè, F | 1 |
| Brockmann, WP; Hübener, KH; Lopez, B; Lorenzen, J; Schwarz, R; Wiegel, T | 1 |
| Koishi, Y; Koyama, H; Masuyama, M; Miyata, K; Oguro, A; Takahashi, T; Takeuchi, K; Tanaka, H; Taniguchi, H | 1 |
| Koyama, H; Miyata, K; Oguro, A; Suganuma, Y; Takahashi, T; Takeuchi, K; Tanaka, H; Taniguchi, H; Torii, T | 1 |
| Hwang, TS; Kim, GE; Kim, SN; Lee, SK; Loh, JK; Park, TK; Suh, CO | 1 |
| Abuchaibe, O; Bilbao, I; Hidalgo, OF; Pardo, F; Rebollo, J; Tangco, E; Vieitez, JM | 1 |
| Broun, ER; Einhorn, LH; Sledge, GW; Tricot, GJ | 1 |
| Canney, P; Junor, E; Yosef, H | 1 |
| Arena, MG; Calabresi, F; Cancrini, A; De Carli, P; Pansadoro, V; Sternberg, CN; Zeuli, M | 1 |
| Denis, B; Focan, C; Focan-Henrard, D; Kreutz, F; Levi, F | 1 |
| Danhauser, LL; Hsi, BP; Hsu, HA; Klostergaard, J; Leroux, ME; Siddik, ZH; Tomasovi, SP | 1 |
| Cappelaere, P; Carde, P; Chauvergne, J; De Gislain, C; Domenge, C; Dufour-Esquerré, F; Hecquet, B; Krakowski, I; Meeus, L; Rolland, F | 1 |
| Allum, WH; Baum, M; Bonnefoi, H; Ebbs, S; O'Brien, ME; Powles, TJ; Seymour, MT; Smith, IE | 1 |
| Cheng, LC; Chiu, CS; Fu, KH; Lee, JW; Mok, CK; Sham, JS | 1 |
| Atahan, L; Celik, I; Firat, D; Kars, A; Ozyar, E; Tekuzman, G | 1 |
| Avramidis, V; Banis, K; Daniilidis, I; Dimitriadis, A; Fountzilas, G; Kalogera-Fountzila, A; Kosmidis, P; Nikolaou, A; Skarlos, D; Sridhar, KS; Vritsios, A; Zaramboukas, T | 1 |
| Anderson, PM; Skubitz, KM | 1 |
| Hui, N; Li, J; Zhu, L | 1 |
| Starr, S | 1 |
| Altman, DG; Parmar, MK; Stewart, LA | 1 |
| Chan, AT; Johnson, PJ; Lee, WY; Leung, SF; Leung, TW; Teo, PM; Yeo, W | 1 |
| Aalders, JG; Boonstra, H; de Bruijn, HW; de Vries, EG; Heesters, MA; Hollema, H; Pras, E; Szabó, BG; Willemse, PH | 1 |
| Ebata, T; Fukata, S; Hattori, T; Hayashi, Y; Kamei, K; Kobayashi, Y; Koide, Y; Kurumiya, Y; Miyata, K; Yuasa, N | 1 |
| Cappelaere, P; Chauvergne, J; De Gislain, C; Domenge, C; Dufour-Esquerre, F; Fournier, C; Hecquet, B; Krakowski, I; Meeus, L; Pion, JM; Rolland, F | 1 |
| Balat, O; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Verschraegen, C | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Ohno, Y; Tokumaru, Y | 1 |
| Kobayashi, K | 1 |
| Canney, PA; Hatton, MQ; Junor, EJ; McGurk, FM; Paul, J; Robertson, AG; Symonds, RP; Yosef, H | 1 |
| Chang, J; Cunningham, D; Gore, M; Hill, A; Hill, M; Moore, H; Nicolson, M; Norman, A; O'Brien, M; Oates, J; Rigg, A; Ross, P; Watson, M | 1 |
| Yamazaki, N | 1 |
| Masumoto, N; Nakamura, M; Nakano, S; Niho, Y; Tabata, H; Takasaki, S | 1 |
| Brown, JM; Dorie, MJ | 1 |
| Baltzer, J; Dimpfl, T; Genz, T; Stumpfe, M | 1 |
| Colleoni, M; Liessi, G; Manente, P; Mastrapasqua, G; Nelli, P; Pancheri, F; Sgarbossa, G; Vicario, G | 1 |
| Dietz, A; Flentje, M; Maiei, H; Nollert, J; Rudat, V; Wannenmacher, M; Weidauer, H | 1 |
| Akasaka, Y; Hanyu, S; Ikeguchi, K; Itoh, H; Numao, A; Osano, H | 1 |
| De Filippis, S; Lalli, A; Nuzzo, A; Recchia, F; Torchio, P | 1 |
| Benasso, M; Merlano, M; Numico, G | 1 |
| Colleoni, M; Graiff, C; Manente, P; Nelli, P; Pancheri, F; Sgarbossa, G; Vicario, G | 1 |
| Furukawa, K; Hayashi, N; Itabashi, T; Morishima, Y; Nakajima, N; Nitta, H; Ohtsubo, Y; Sano, W; Sugiura, T; Takagi, K; Tashiro, T; Toyoda, Y; Yamamori, H | 1 |
| Beuzeboc, P; Deffontaines, D; Diéras, V; Dorval, T; Garcia-Giralt, E; Jouve, M; Palangie, T; Pouillart, P; Scholl, S | 1 |
| Ahlgren, JD; Auerbach, M; Fryer, D; Fryer, JG; Lokich, JJ; Wampler, GL | 1 |
| Devriendt, D; Klastersky, J | 1 |
| Fietkau, R; Iro, H; Kirschner, MJ; Sauer, R; Waldfahrer, F | 1 |
| Bastounis, EA; Baxevanis, CN; Papadhimitriou, SI; Papadopoulos, NG; Papamichail, M; Tsavaris, NB; Zarkadis, IK | 1 |
| Beuzeboc, P; Deffontaines, D; Diéras, V; Dorval, T; Garcia-Giralt, E; Jouve, M; Omodei Zorini, C; Palangie, T; Pouillart, P; Scholl, S | 1 |
| de Vries, EG; Mulder, NH; Sluiter, WJ; Spijkervet, FL; Timens, W; Timmer-Bosscha, H; van der Graaf, WT; Wymenga, AN | 1 |
| Cortés-Funes, H; García-Conde, J; Hornedo, J; Lluch, A; López, J; Sola, C; Solano, C | 1 |
| Benavides, M; Cortés-Funes, H; García Conde, J; Hornedo, J; Lluch, A; López López, J; Sola, C; Solano, C | 1 |
| Liang, S; Wu, J; Zhang, Z | 1 |
| Tsukuda, M | 2 |
| Bettscheider, C; Dietz, A; Eble, MJ; Rudat, V; Vanselow, B; Wollensack, P | 1 |
| Greco, FA; Hainsworth, JD; Meluch, AA | 1 |
| Birkenhake, S; Kühn, R; Martus, P; Sauer, R; Schrott, KM | 1 |
| Hara, R; Isobe, K; Ito, H; Kawada, T; Kitahara, H; Kubo, A; Machida, N; Shigematsu, N; Takano, H; Uchida, Y; Uno, T; Yasuda, S | 1 |
| Makishima, K; Shimizu, T; Yoshida, M | 1 |
| Ferrante, K; Huberman, MS; Jenkins, RL; Lewis, WD; Sanz-Altamira, PM; Stuart, KE | 1 |
| Friberg, B; Glimelius, B; Goldman, S; Svensson, C | 1 |
| Botto, F; Ghio, E; Neri, E; Pensa, F; Pronzato, P; Tognoni, A; Vaira, F; Vigani, A | 1 |
| Eisele, DW; Forastiere, AA; Lee, DJ; Westra, WH | 1 |
| Baars, JW; Bakx, R; Borger, JH; Dalesio, O; Koning, CC; Nooijen, WJ; Peterse, JL; Richel, DJ; Rodenhuis, S; Rutgers, E; Schornagel, JH; van der Wall, E | 1 |
| Baillet, F; Chrétien, Y; Dufour, B; Durdux, C; Housset, M; Méjean, A | 1 |
| Aebi, S; Fink, D; Fink, JL; Gordon, R; Howell, SB; Kim, HK; Zheng, H | 1 |
| Hafström, L; Heath, D; Howell, S; Lindnér, P; Naredi, P | 1 |
| Nakamura, M; Sawada, K; Sawada, M; Suzuki, Y | 1 |
| Fountzilas, G; Gatter, KC; Georgoulias, V; Giatromanolaki, A; Harris, AL; Koukourakis, MI | 1 |
| Andersen, J; Anderson, KC; Cook, J; Dzieczkowski, JS; McGonigal, M; Sugrue, M | 1 |
| Aravantinos, G; Bafaloukos, D; Bakoyiannis, C; Katsifis, G; Kosmidis, P; Samonis, G; Skarlos, D | 1 |
| Hennequin, C; Maylin, C | 1 |
| Kaern, J; Paulsen, T; Tropé, C | 1 |
| Berry, DA; Cirrincione, C; Costanza, ME; Frei, E; Henderson, IC; McIntyre, OR; Norton, L; Schilsky, RL; Weiss, RB; Winer, E; Wood, WC | 1 |
| Bachert, P; Becker, M; Dietz, A; Knopp, MV; Rudat, V; Schlemmer, HP; van Kaick, G; Vanselow, B; Wannenmacher, M; Weidauer, H; Wollensack, P; Zuna, I | 1 |
| Jelić, S; Nikolić-Tomasević, Z; Popov, I; Radosavljević, D | 1 |
| Colombo, A; Cormio, G; Landoni, F; Maneo, A; Mangioni, C; Pellegrino, A; Placa, F | 1 |
| Fornasiero, A; Friso, ML; Lise, M; Marchiori, E; Pucciarelli, S; Toppan, P; Vieceli, G | 1 |
| Ebeling, O; Eckel, H; Schröder, M; Stennert, E; Volling, P | 1 |
| Hagiwara, A; Kitamura, K; Koh, T; Kunishima, S; Okamoto, K; Otsuji, E; Shirasu, M; Taniguchi, H; Yamagishi, H; Yamaguchi, A; Yamaguchi, T | 1 |
| Bang, YJ; Chie, EK; Heo, DS; Hong, S; Kim, KH; Park, CI; Sung, MW; Wu, HG | 1 |
| Carl, UM; Hartmann, KA; Lammering, G; Pape, H | 1 |
| Altmann, S; Hoffmanns, H | 1 |
| Bonvoisin, S; Desseigne, F; Gerard, JP; Morignat, E; Mornex, F; Pommier, P; Taieb, S; Vaillant, E | 1 |
| Alfonsi, M; Bardet, E; Bergerot, P; Bertrand, P; Calais, G; Germain, T; Oudinot, P; Rhein, B; Sire, C; Tortochaux, J | 1 |
| Abraham, R; Crump, M; Goss, PE; Nagy, T | 1 |
| Fountzilas, G; Gatter, KC; Giatromanolaki, A; Harris, AL; Koukourakis, MI; Sivridis, E | 1 |
| Barroso, A; Lencastre, H; Nogueira, R; Parente, B; Seada, J | 1 |
| Focan, C; Focan-Henrard, D; Kreutz, F; Moeneclaey, N | 2 |
| Amsrud, T; Chen, V; Forler, PA; Menon, K; Phares, VG; Shih, C; Teicher, BA | 1 |
| Hsu, CP; Yang, CC; Yang, SD | 1 |
| Chen, J; Wang, J; Wang, S | 1 |
| Antoine, EC; Coeffic, D; Khayat, D | 1 |
| Dang, V; Gilbert, R; Heller, R; Hickey, J; Jaroszeski, MJ; Pottinger, C | 1 |
| McNamee, D | 1 |
| Cantore, M; Ceravolo, C; Cornalba, G; Fiorentini, G; Frassoldati, A; Guadagni, S; Miserocchi, L; Muchmore, JH; Pederzoli, P; Smerieri, F | 1 |
| Berno, E; Canaparo, R; Casale, F; Della Pepa, C; Eandi, M; Fornari, G; Muntoni, E; Pons, N; Zara, GP | 1 |
| Kim, GE; Kim, SN; Kim, SW; Park, TK; Suh, CO | 1 |
| Anker, G; Bengtsson, NO; Bergh, J; Blomqvist, C; Erikstein, B; Holte, H; Kellokumpu-Lehtinen, P; Lidbrink, E; Lindman, H; Ljungman, P; Malmström, P; Nilsson, J; Ottosson, S; Salminen, E; Söderlund, G; Wiklund, T; Wilking, N; Wist, E | 2 |
| Beijnen, JH; Mathôt, RA; Schellens, JH; van den Bongard, HJ | 1 |
| Bradford, CR; Carpenter, V; Eisbruch, A; Miller, T; Strawderman, M; Tang, G; Terrell, JE; Thornton, AF; Urba, SG; Wolf, GT | 1 |
| Franco, DA; Greenberg, HS | 1 |
| Adelman, D; Breed, J; Fyfe, G; Gaudreault, J; Gordon, MS; Holmgren, E; Margolin, K; Novotny, W; Stalter, S | 1 |
| Dowell, JE; Garrett, AM; Hande, KR; Johnson, DH; Shyr, Y | 1 |
| Anchisi, S; Anguenot, JL; Bonnefoi, H; Hügli, A; Mermillod, B; Sappino, AP; Schafer, P | 1 |
| Dunst, J; Grabenbauer, GG; Kühn, R; Papadopoulos, T; Rödel, C; Sauer, R; Schrott, KM | 2 |
| Antman, KH | 1 |
| Boudet, MJ; Gayet, B; Hennequin, C; Lecomte, T; Mal, F; Maylin, C; Perniceni, T; Raymond, E; Salemkour, A | 1 |
| Bittner, C; Feyerabend, T; Peters, SO; Raap, M; Remmert, S; Robins, IH; Sieg, P; Sommer, K; Wiedemann, GJ | 1 |
| de Jong, S; de Leij, LF; de Vries, EG; Mulder, NH; Ruiters, MH; Schröder, CP; van der Graaf, WT; van der Zee, AG; Wisman, GB | 1 |
| Boogerd, W; Hamburger, HL; Muller, MJ; Schagen, SB; van Dam, FS | 1 |
| Bergaglio, M; Bertelli, G; Bertoglio, S; Bighin, C; Del Mastro, L; Lambiase, A; Melioli, G; Pietra, G; Rosso, R; Semino, C; Sertoli, MR; Signorini, A; Venturini, M; Viscoli, C | 1 |
| Kovács, AF | 1 |
| Berger, R; Brenner, H; Ghodsizade, E; Katz, A; Rath, P; Tichler, T | 1 |
| Dietz, A; Eckel, HE; Flentje, M; Mueller, RP; Rudat, V; Schroeder, M; Staar, S; Stuetzer, H; Volling, P | 1 |
| Fujii, M; Ishiguro, R; Ohno, Y; Tashiro, M; Yamashita, T | 1 |
| Baker, MN; Burris, HA; Greco, FA; Hainsworth, JD; Meluch, AA; Morrissey, LH | 1 |
| Hess, KR; Jaeckle, KA; Kyritsis, AP; Levin, VA; Prados, MD; Wong, ET; Yung, WK | 1 |
| Coudray, AM; Faivre, S; Gespach, C; Louvet, C; Raymond, E | 1 |
| Liu, H; Qiao, T; Xin, L | 1 |
| Cseke, L; Horváth, G; Horváth, OP; Kalmár, K; Varga, G | 1 |
| Abashin, SIu; Artamonova, EV; Ermilova, VD; Khaĭlenko, VA; Komov, DV; Manziuk, LV; Mikhina, ZP | 1 |
| Martín, M | 1 |
| de Cornulier, J; Durand, M; Guillot, A; Martin, C; Prades, JM; Schmitt, TM; Simon, PG; Timoshenko, AP | 1 |
| Giacchetti, S | 1 |
| Avigan, D; Elias, AD; Frei, E; Ibrahim, J; Joyce, R; McCauley, M; Reich, E; Richardson, P; Wheeler, C | 1 |
| Guiney, MJ; Jefford, M; Ngan, SY; Rischin, D; Smith, JG; Toner, GC | 1 |
| Carter, DL; Folz, RJ; Jamieson, TA; Lind, PA; Marks, LB; Prosnitz, LR; Vredenburgh, JJ | 1 |
| Bowman, LC; Douglass, EC; Finegold, MJ; Katzenstein, HM; London, WB; Plaschkes, J; Reynolds, M | 1 |
| Conradt, C; Dietz, A; Dollner, R; Kallinowski, F; Rudat, V; Vanselow, B; Weidauer, H | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Brockstein, BE; Fung, BB; Haraf, DJ; Kies, MS; List, MA; Mittal, BB; Pelzer, H; Portugal, L; Rademaker, AW; Rosen, FR; Stenson, K; Vokes, EE; Weichselbaum, RR; Witt, ME | 1 |
| Cai, L; Liao, Q; Wu, Y; Zhao, Y; Zhu, Y | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M | 1 |
| Liu, J; Tang, WJ; Yu, RC | 1 |
| Aomi, S; Kameoka, S; Kaneyasu, Y; Mitsuhashi, N; Nakabayashi, M; Nishikawa, T; Okawa, T; Saito, R; Sawada, T; Seshimo, A; Yajima, M | 1 |
| Davis, R; Lance, R; Peterson, AC | 1 |
| Adem, C; Chiras, J; Guillevin, R; Lo, D; Reb, P; Vallée, JN | 1 |
| Allen, M; Andreyev, J; Cunningham, D; Hill, M; Kelleher, M; Norman, A; Tebbutt, NC | 1 |
| Bodisch, A; Ferenci, P; Gangl, A; Jessner, W; Novacek, G; Püspök, A; Vogelsang, H; Wenzl, E | 1 |
| Focan, C; Focan-Henrard, D; Kreutz, F; Moeneclaye, N | 1 |
| Behtash, N; Ghaemmaghami, F; Khanafshar, N; Modares, M; Moosavi, A; Toogeh, G; Yarandi, F | 1 |
| Gejyo, F; Ito, K; Iwashima, A; Kagamu, H; Maruyama, Y; Miyao, H; Sato, T; Suzuki, E; Tanaka, J; Yoshizawa, H | 1 |
| Gómez-Meda, BC; Gutiérrez-Franco, A; Morgan-Villela, G; Ramos-Ibarra, ML; Torres-Bugarín, O; Ventura-Aguilar, A; Zamora-Perez, A; Zúñiga-González, G | 1 |
| Bergh, J; Bolund, C; Brandberg, Y; Erikstein, B; Hietanen, P; Kaasa, S; Michelson, H; Nilsson, B; Nilsson, J; Wiklund, T; Wilking, N | 1 |
| Dietz, A; Helbig, M; Knopp, MV; Lumer, M; Schlemmer, HP | 1 |
| Arya, LS; Sethi, A; Sridhar, MR; Thavaraj, V | 1 |
| Hansen, SW; Homburg, KM; Johnsen, HE; Kamby, C; Nielsen, DL; Roer, O; Sliffsgaard, D; Svane, IM | 1 |
| Alfonsi, M; Bardet, E; Bergerot, P; Calais, G; Denis, F; Garaud, P; Germain, T; Rhein, B; Sire, C; Tortochaux, J | 1 |
| Argiris, A; Brockstein, BE; Haraf, DJ; List, MA; Mittal, BB; Pelzer, H; Portugal, L; Rosen, FR; Stenson, K; Vokes, EE; Weichselbaum, RR; Witt, ME | 1 |
| Agbemadzo, B; Cohen, JA; Flood, TP; Holloway, N; Mullai, N; Osafo, DC; Renta, V; Samuel, J | 1 |
| Beuzeboc, P; Debré, B; Peyromaure, M; Ponvert, D; Slama, J; Zerbib, M | 1 |
| An, P; Cai, HY; Li, SY; Wei, JC; Yu, B; Zuo, FY | 1 |
| Alexander, H; Alexander, S; Min, J; Stegner, AL | 1 |
| Dempsey, DT; Furukawa, S; Gupta, D; McClurken, JB; Piacentino, V; Ross, K; Stepnowski, D | 1 |
| Alzieu, C; Bardou, VJ; Bladou, F; George, L; Gravis, G; Salem, N; Serment, G; Tallet, A | 1 |
| Li, DP; Li, HQ; Li, QS; Lu, CH; Sheng, XG; Song, XR; Tang, L; Wang, XW | 1 |
| Birtle, AJ; Harland, SJ; Newby, JC | 1 |
| Economopoulos, T; Farmakis, D; Gaglia, A; Koumarianou, A; Koumpou, M; Kountourakis, P; Mitrou, P; Nikolaou, M; Papaxoinis, G; Pectasides, D; Pectasides, M; Raptis, SA | 1 |
| Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Huang, GC; Kuo, YY; Lin, MH; Liu, SY; Liu, YC | 1 |
| O'Boyle, K | 1 |
| Huober, J; Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Chen, YT; Hong, GB; Jiang, RJ; Luo, JH; Xu, LF; Xu, LY; Zhou, JX | 1 |
| Ambrosi, A; Friso, ML; Lise, M; Marino, F; Pasetto, L; Pucciarelli, S; Russo, V; Toppan, P; Urso, E | 1 |
| Gómez-Meda, BC; Gutiérrez-Franco, A; Morga-Villela, G; Ramos-Ibarra, ML; Torres-Bugarín, O; Ventura-Aguilar, A; Zamora-Perez, A; Zúñiga-González, G | 1 |
| Cantore, M; Caudana, R; Ceravolo, C; Comella, G; Del Freo, A; Fiorentini, G; Luppi, G; Mambrini, A; Marangolo, M; Miserocchi, L; Piazza, E; Rabbi, C; Rosati, G; Zamagni, D | 1 |
| Bader, SB; Louie, J; Molendyk, J; Phillips, M; Regan, J; Ross, HJ; Ruzich, J; Seligman, M; Seung, SK; Skokan, L; Smith, JW; Soo, E | 1 |
| Dietz, A; Dollner, R; Hildebrandt, G; Weber, A | 1 |
| Chang, HM; Choi, SJ; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, YH; Ryu, BY | 1 |
| Brener, J; Chaitchik, S; Czerniak, A; Hayat, H; Schachter, P; Shimonov, M | 1 |
| Biquet, JF; David, A; Delforge, M; Focan, C; Focan-Henrard, D; Graas, MP; Kreutz, F; Longrée, L; Materne, R; Moeneclaey, N; Weerts, J | 1 |
| David, A; Focan, C; Focan-Henrard, D; Graas, MP; Kreutz, F; Longrée, L; Moeneclaey, N | 1 |
| Bury, J; David, A; Focan, C; Focan-Henrard, D; Graas, MP; Kreutz, F; Longree, L; Matus, G; Moeneclaey, N | 1 |
| Argiris, A; Jayaram, P; Pichardo, D | 1 |
| Katori, H; Nozawa, A; Tsukuda, M | 1 |
| Bhat, MK; Chhipa, RR; Singh, S; Vijayakumar, MV | 1 |
| Lopes, G; Rocha Lima, CM | 1 |
| Ott, OJ; Sauer, R; Strnad, V; Windschall, A | 1 |
| Burman, S; Honavar, SG; Murthy, R; Naik, MN; Reddy, VA; Vemuganti, GK | 1 |
| Akerman, P; Barnett, JM; Berkenblit, A; Harrington, D; Iannitti, D; Maia, C; Miner, T; Nadeem, A; Rathore, R; Roye, D; Safran, H; Stuart, K; Tsai, JY | 1 |
| Busse, PM; Goguen, L; Guadagnolo, BA; Haddad, RI; Norris, CM; Posner, MR; Sullivan, CA; Tishler, R; Weeks, L; Wirth, LJ | 1 |
| Biel, MA; El-Naggar, AK; Machtay, M; Rosenthal, DI; Sinard, RJ; Weber, RS; Yom, SS | 1 |
| Chou, W; Lee, N; Puri, DR | 1 |
| Barletta, E; Bruni, GS; D'Angelo, R; Daniele, B; Ferrari, E; Fiore, F; Formato, R; Iaffaioli, RV; Ottaiano, A; Pignata, S; Tortoriello, A; Turitto, G | 1 |
| Brom, R; Candelaria, M; Cantu, D; Cetina, L; Chanona, J; de la Garza, J; Dolores, R; Duenas-Gonzalez, A; Gonzalez, A; Lopez-Graniel, C; Uribe, J | 1 |
| Boige, V; Ducreux, M; Elias, D; Lasser, P; Lebray, P; Locher, C; Malka, D | 1 |
| Agrafiotis, A; Giannikos, L; Kazaz, M; Polyzos, A; Sfikakis, P; Zonas, C | 1 |
| Bando, E; Endou, Y; Kawamura, T; Miyamoto, K; Sasaki, T; Shimada, T; Tanaka, M; Tochiori, S; Yonemura, Y | 1 |
| Fujii, M | 1 |
| Perilongo, G; Roebuck, DJ | 1 |
| Belka, C; Budach, V; Budach, W; Dietz, K; Hehr, T | 1 |
| Dietz, A; Eckel, HE; Eich, HT; Flentje, M; Guntinas-Lichius, O; Kocher, M; Mueller, RP; Rudat, V; Schroeder, M; Schroeder, U; Semrau, R; Staar, S; Stuetzer, H; Volling, P | 1 |
| Horiuchi, C; Kawakami, M; Kondo, N; Masuda, Y; Matsuda, H; Mikami, Y; Nagao, J; Nishimura, G; Taguchi, T; Tsukuda, M; Yabuki, K; Yoshida, T | 1 |
| Bandou, E; Endou, Y; Sasaki, T; Sawa, T; Sugarbaker, PH; Yonemura, Y; Yoshimitsu, Y | 1 |
| Cantore, M; Capelli, P; Fiorentini, G; Iacono, C; Lombardi, M; Mambrini, A; Pacetti, P; Pagani, M; Pederzoli, P; Pulica, C; Serio, G; Torri, T | 1 |
| Busse, PM; Case, M; Costello, R; Goguen, L; Haddad, RI; Mahadevan, A; Norris, CM; Posner, MR; Sammartino, D; Stowell, S; Sullivan, C; Tishler, RB; Wirth, LJ | 1 |
| Kreĭnina, IuM; Povarova, EV; Shevchenko, LN; Shipilova, AN; Titova, VA | 1 |
| Amellal, N; Awada, A; Borel, C; Bourhis, J; Duck, L; Geoffrois, L; Harstrick, A; Hitt, R; Humblet, Y; Lopez-Pousa, A; Mesia, R; Rivera, F; Rosine, D; Schueler, A; Vega Villegas, ME | 1 |
| Aitini, E; Cantore, M; Caudana, R; Ceravolo, C; Comella, G; Del Freo, A; Fiorentini, G; Luppi, G; Mambrini, A; Marangolo, M; Miserocchi, L; Piazza, E; Rosati, G; Zamagni, D | 1 |
| Bowman, L; Castleberry, RP; Chen, Z; Finegold, M; Greffe, B; Katzenstein, H; Krailo, MD; London, WB; Malogolowkin, MH; Newman, K; Reynolds, M; Rowland, J; Womer, RB | 1 |
| Ajay, AK; Bhat, MK; Chhipa, RR; Singh, S; Upadhyay, AK; Vijayakumar, MV | 1 |
| Ayala, R; Cortés-Funes, H; Gamarra, S; Gilsanz, F; Guzman, C; Hitt, R; Hornedo, J; Jimeno, A; López, JM; Quintela-Fandino, M | 1 |
| Cho, JH; Keum, KC; Kim, GE; Kim, YB; Lee, CG; Seong, J; Suh, CO | 1 |
| Chen, ZM; Jiang, Y; Qiu, XH; Yang, YX; Zhang, SQ | 1 |
| Bryan, B; Dezube, BJ; Konstantinopoulos, PA; Pantanowitz, L; Schlecht, HP | 1 |
| Ajani, J; Cox, JD; Komaki, R; Liao, Z; Liu, H; Swisher, S; Wang, SL | 1 |
| Kong, W; Zhang, S | 1 |
| Andry, G; Awada, A; Dequanter, D; Hien Nguyen, T; Lalami, Y; Lemort, M; Lothaire, P; Vandevelde, L | 1 |
| Ajay, AK; Bhat, MK; Singh, S; Upadhyay, AK | 1 |
| Fujimoto, S | 1 |
| Fortner, BV; Houts, AC; Schwartzberg, LS | 1 |
| Bendell, JC; Blobe, GC; Czito, BG; D'Amico, TA; Fernando, NH; Harpole, DH; Honeycutt, W; Hurwitz, HI; Kelsey, CR; Morse, MA; Willett, CG; Yu, D | 1 |
| Cseke, L; Esik, O; Horváth Ors, P; Kalmár, K; Papp, A; Yousuf, AF | 1 |
| Ancona, E; Boso, C; Chiarion-Sileni, V; Corti, L; Del Bianco, P; Innocente, R; Mazzarotto, R; Pigozzo, J; Ruol, A; Tomassi, O | 1 |
| Daimon, T; Furutani, K; Fuwa, N; Kodaira, T; Nakamura, T; Tachibana, H | 1 |
| Feng, YL; Li, JD; Li, MD; Liu, JH; Shi, HL; Xiao, Y | 1 |
| Chan, K; Della-Bianca, C; Kraus, D; Lee, NY; Mechalakos, JG; Narayana, A; O'Meara, W; Pfister, DG; Shah, JP; Wolden, SL; Zhung, J | 1 |
| Jia, HS; Sun, T; Zhang, JR | 1 |
| El-Rayes, B; Griffith, KA; Kalemkerian, GP; Muler, JH; Philip, PA; Schneider, BJ; Zalupski, MM | 1 |
| Chiba, N; Gamoh, M; Ishioka, C; Kakudo, Y; Kato, S; Murakawa, Y; Nishino, Y; Ohori, H; Ohtsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Suzuki, T; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T | 1 |
| Baron, B; de la Valette, V; Focan, C; Focan-Henrard, D; Giacchetti, S; Karaboué, A; Kreutz, F; Lévi, F | 1 |
| Bischoff, A; Budach, V; Füller, J; Köhler, C; Marnitz, S; Roth, C; Schneider, A; Wendt, T | 1 |
| Akerman, P; Berkenblit, A; Chauhan, B; Cruff, D; Evans, D; Habr, F; Harrington, D; Iannitti, D; Kennedy, T; Maia-Acuna, C; Miner, T; Safran, H; Sears, D; Stuart, K | 1 |
| Creemers, GJ; Nieuwenhuijzen, GA; Romme, EA; Rutten, HJ; van de Schoot, L; van der Sangen, MJ; van Driel, OJ; van Lijnschoten, G | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Alberts, SR; Fitch, TR; Foster, NR; Jatoi, A; Lair, BS; Martenson, JA; McLeod, HL; Moore, DF; Nichols, F; Tschetter, LK | 1 |
| Cho, YH; Hah, JH; Heo, DS; Kim, DW; Kim, KH; Lee, SH; Rhee, CS; Sung, MW; Wu, HG | 1 |
| Klem, ML; Kraus, D; Lee, NY; Mechalakos, JG; Pfister, DG; Shah, J; Shaha, A; Singh, B; Wolden, SL; Zelefsky, MJ | 1 |
| Aaronson, NK; Buijs, C; de Vries, EG; Hupperets, P; Mourits, MJ; Nooij, MA; Post, WJ; Rodenhuis, S; Seynaeve, CM; Smit, WJ; TenVergert, EM; van der Wall, E; van Hoesel, QG; van Tinteren, H; Voest, E; Willemse, PH | 1 |
| Rödel, C; Sauer, R; Weiss, C | 1 |
| Ballardini, M; Bassi, C; Cantore, M; Fiorentini, G; Guadagni, S; Iacono, C; Mambrini, A; Orlandi, M; Pacetti, P; Torri, T | 1 |
| Aristu, JJ; Coco, C; Díaz-González, JA; Guillem, JG; Hernandez-Lizoain, JL; Jeong, SY; Leon, R; Minsky, BD; Nitti, D; Pucciarelli, S; Riedel, ER; Rodriguez-Bigas, MA; Valentini, V; Wong, WD | 1 |
| Furutani, K; Fuwa, N; Kodaira, T; Nakamura, T; Tachibana, H | 2 |
| Calzolari, F; Cecconetto, L; Giampalma, E; Golfieri, R; Milandri, C; Passardi, A; Tison, C | 1 |
| Daimon, T; Furutani, K; Fuwa, N; Inokuchi, H; Kodaira, T; Nakahara, R; Nakamura, T; Tachibana, H; Tomoda, T | 1 |
| Bhide, SA; Harrington, KJ; Nutting, CM | 1 |
| Pajak, TF; Ridge, JA; Trotti, A | 1 |
| Bagarry, D; Barrau, K; Bourgeois, A; Deville, JL; Duffaud, F; Favre, R; Giorgi, R; Giovanni, A; Pignon, T; Salas, S; Zanaret, M | 1 |
| Bradford, CR; Carey, TE; Chepeha, DB; Cordell, KG; D'Silva, NJ; Eisbruch, A; Kumar, B; Kurnit, DM; Lee, JS; Mason, HL; Miller, TH; Prince, ME; Taylor, JM; Teknos, TN; Tsien, CI; Urba, SG; Wallace, NE; Wolf, GT; Worden, FP; Yang, K | 1 |
| Argiris, A; Brockstein, BE; Cohen, EE; Haraf, DJ; Kistner, EO; Mittal, BB; Rosen, F; Salama, JK; Stenson, KM; Vokes, EE; Witt, ME | 1 |
| Arnedos, M; Ashley, S; Johnston, S; Nerurkar, A; Popat, S; Sirohi, B; Smith, IE; Walsh, G | 1 |
| Hee, SW; Leong, SS; Lim, WT; Poon, D; Rajan, S; Tan, EH; Tay, MH; Toh, CK; Wee, J | 1 |
| Chen, Q; Lin, ZQ; Tan, YT; Wang, LJ; Zhang, BZ; Zhang, X | 1 |
| Button, MR; Crosby, TD; Croydon, ES; Morgan, CA; Roberts, SA | 1 |
| Amellal, N; Benasso, M; Bokemeyer, C; Cupissol, D; De Raucourt, D; Erfan, J; Hitt, R; Kawecki, A; Kienzer, HR; Mesia, R; Peyrade, F; Remenar, E; Rivera, F; Rottey, S; Schueler, A; Vermorken, JB; Vynnychenko, I; Zabolotnyy, D | 1 |
| Li, HP; Li, LY; Luo, B; Pan, M; Shu, KY; Zeng, SY | 1 |
| Chen, J; Liang, D; Wu, X; Yuan, Y; Zhang, Y | 1 |
| Fuwa, N; Inokuchi, H; Kodaira, T; Mizoguchi, N; Nakahara, R; Nakamura, T; Tachibana, H; Takada, A; Tomita, N; Tomoda, T | 1 |
| Chung, HH; Kang, SB; Kim, JW; Kim, K; Park, NH; Song, YS | 1 |
| Chen, EX; Le Tourneau, C | 1 |
| Ball, DL; Macmanus, MP; Michael, M; Millward, MJ; Plumridge, NM; Rischin, D; Wirth, A; Yuen, K | 1 |
| Gutweiler, JR; Kim, HB; Kozakewich, HP; Marcus, KJ; Shamberger, RC; Weldon, CB; Yu, DC | 1 |
| Korytova, LI; Sokurenko, VP; Suvorova, IuV; Tarazov, PG | 1 |
| Buchmann, C; Ferk, F; Fuerhacker, M; Grillitsch, B; Grummt, T; Knasmüller, S; Lenz, K; Majer, B; Misík, M; Nersesyan, A; Parzefall, W; Uhl, M; Vital, M | 1 |
| Hanamura, H; Horiuchi, C; Kawakami, M; Matsuda, H; Mikami, Y; Nishimura, G; Satake, K; Taguchi, T; Takahashi, M; Tsukuda, M; Utsumi, A; Watanabe, M | 1 |
| Ebina, Y; Hosaka, M; Mitamura, T; Moriwaki, M; Ohba, Y; Sakuragi, N; Takeda, M; Todo, Y; Watari, H | 1 |
| Chan, K; Fury, M; Humm, J; Lee, N; Ling, CC; Nehmeh, S; Schöder, H | 1 |
| Burris, HA; Greco, FA; Hainsworth, JD; Kuzur, M; Lunin, S; Markus, TM; Shipley, D; Spigel, DR | 1 |
| Jaén, P; Muñoz-Zato, E; Pérez, B; Truchuelo, M; Vano-Galvan, S | 1 |
| Cano, ER; Carrau, RL; Caylakli, F; Ferris, RL; Gooding, WE; Johnson, JT; Lai, SY; Myers, EN; Simenthal, AA; Snyderman, CH | 1 |
| Barkati, M; Charpentier, D; Clavel, S; Coulombe, G; Després, P; Donath, D; Fortin, B; Guertin, L; Nguyen-Tan, PF; Olivier, MJ; Soulières, D; Tabet, JC | 1 |
| Kim, JY; Lim, MC; Park, SY; Yoo, CW | 1 |
| Fuwa, N; Kodaira, T; Nakamura, T; Tachibana, H; Tomita, N; Yokouchi, J | 1 |
| Eng, C; Pathak, P | 1 |
| Bradford, CR; Chepeha, DB; Eisbruch, A; Emerick, K; Hadjiski, L; Hogikyan, N; Lassig, AA; Lee, JS; Mason, HL; Miller, TH; Moyer, J; Mukherji, S; Prince, ME; Taylor, JM; Teknos, TN; Tsien, CI; Urba, SG; Wallace, NE; Wolf, GT; Worden, FP | 1 |
| Boezen, HM; Buijs, C; de Vries, EG; Hollema, H; Mourits, MJ; Ten Hoor, KA; Willemse, PH | 1 |
| de Villiers, EM; Debus, J; Helmke, B; Lindel, K; Simon, C; Weber, KJ | 1 |
| Honova, H; Kralova, D; Pazdro, A; Pazdrova, G; Petruzelka, L; Smejkal, M; Zemanova, M | 1 |
| Levine, PA; Petroni, G; Read, P; Reibel, J; Thomas, CY | 1 |
| Corry, P; Moros, EG; Peñagarícano, JA; Ratanatharathorn, V; Yan, Y | 1 |
| Arts, HJ; de Bock, GH; de Jong, S; de Vries, EG; Eijsink, JJ; Hollema, H; Maduro, JH; Mom, CH; Noordhuis, MG; Pras, E; ten Hoor, KA; van der Zee, AG | 1 |
| Basu, S; Faber, LP; Kim, AW; Liptay, MJ; Miller, C; Milman, S; Warren, WH | 1 |
| Chen, CH; Chiang, PH; Kang, CH | 1 |
| Beal, K; Damast, S; Elkin, E; Fornier, MN; Ho, AY; Ishill, N; McCormick, B; Montgomery, L | 1 |
| Bhat, MK; Sharma, A; Upadhyay, AK | 1 |
| Cullen, KJ; Goloubeva, O; Haddad, RI; Nikitakis, N; Posner, MR; Sarlis, NJ; Schumaker, L; Tan, M | 1 |
| Bradford, CR; Chepeha, DB; Divi, V; Eisbruch, A; Hogikyan, ND; Lee, JS; Moyer, JS; Prince, ME; Teknos, TN; Tsien, CI; Urba, SG; Wolf, GT; Worden, FP | 1 |
| Gupta, S; Mallik, S; Munshi, A | 1 |
| Chang, CS; Chang, TH; Lin, JT; Shih, SC | 1 |
| Chen, QY; Guo, X; Hong, MH; Lu, X; Xiang, YQ; Zeng, Q | 1 |
| Cao, Q; Chen, Q; Cheng, C; Jin, Y; Pan, J; Verstovsek, S | 1 |
| Cos, M; Mesía, R; Palmero, R; Vázquez, S; Vilajosana, E | 1 |
| Benasso, M; Bokemeyer, C; Cupissol, D; Curran, D; De Raucourt, D; Delord, JP; Gross, A; Hitt, R; Kawecki, A; Kienzer, H; Koralewski, P; Mesía, R; Rivera, F; Rottey, S; Vermorken, JB | 1 |
| Bélair, M; Charpentier, D; Clavel, S; Després, P; Donath, D; Fortin, B; Guertin, L; Khaouam, N; Nguyen-Tan, PF; Soulières, D | 1 |
| Niculescu-Duvaz, I | 1 |
| Aleman, BM; Boot, H; Cats, A; Courrech Staal, EF; Jansen, EP; van Coevorden, F; van Sandick, JW; van Velthuysen, ML | 1 |
| Li, JF; Lin, BY; Lu, AP; Ouyang, T; Qi, M; Xie, YT | 1 |
| Ball, DL; Binns, D; Ding, Z; Herschtal, A; Hicks, RJ; Hogg, A; Mac Manus, MP | 1 |
| Chung, HH; Kang, SB; Kim, HJ; Kim, HS; Kim, JW; Kim, JY; Kim, K; Kim, YB; Park, NH; Song, YS | 1 |
| Bafana, R; Hasan, Y; Hasselle, MD; Kochanski, JD; Mell, LK; Mundt, AJ; Nath, SK; Roeske, JC; Rose, BS; Yashar, CM | 1 |
| Matouskova, E; Mladkova, J; Sanda, M; Selicharova, I | 1 |
| Bergin, P; Damianovich, D; Findlay, M; Hanning, F; Hill, A; McKeage, MJ; Thompson, P | 1 |
| Cui, NJ; Cui, TT; Pan, JJ; Tian, Y; Wu, SX; Xu, BY; Zhao, C | 1 |
| Anders, C; Bran, G; Faber, A; Hörmann, K; Sadick, H; Sauter, A; Schultz, JD | 1 |
| Chung, HH; Kang, SB; Kim, K; Kim, MJ; Kim, YH; Lee, JY; Park, NH; Song, YS | 1 |
| Aneiros-Fernandez, J; Arias-Santiago, S; Husein-ElAhmed, H; Naranjo-Sintes, R | 1 |
| Akhtar, MS; Fatimi, S; Kousar, F; Masood, M | 1 |
| Debus, J; Habl, G; Hajda, J; Hof, H; Jensen, AD; Krempien, R; Münter, MW; Potthoff, K; Simon, C; Uhl, M | 1 |
| Huang, XE; Jiang, Y; Li, Y; Xiang, J; Yan, PW | 1 |
| Cornelissen, S; de Bruin, M; de Vries, EGE; Froklage, FE; Hauptmann, M; Holtkamp, M; Linn, SC; Lips, EH; Nederlof, PM; Rodenhuis, S; Schmidt, MK; Schrama, JG; van Beers, EH; van de Vijver, MJ; van Tinteren, H; Vollebergh, MA; Wesseling, J; Wessels, LFA | 1 |
| Chang, AJ; Grigsby, PW; Richardson, S; Schwarz, JK | 1 |
| Asano, A; Hirasawa, N; Horikawa, Y; Ishihara, S; Itoh, Y; Koyama, K; Murao, T; Naganawa, S; Nomoto, Y; Obata, Y; Sasaoka, M; Suzuki, K | 2 |
| Clavel, S; Després, P; Donath, D; Fortin, B; Guertin, L; Khaouam, N; Nguyen, DH; Nguyen-Tan, PF; Soulières, D | 1 |
| Devlin, PM; Haddad, RI; Holupka, EJ; Posner, MR; Sarlis, NJ; Sher, DJ; Tishler, RB | 1 |
| Bélair, M; Charron, MP; Clavel, S; Delouya, G; Després, P; Filion, E; Fortin, B; Guertin, L; Nguyen-Tan, PF; Soulières, D | 1 |
| Albarghach, N; Corcos, L; Hatt, M; Le Rest, CC; Metges, JP; Pradier, O; Tixier, F; Visvikis, D | 1 |
| Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS | 1 |
| Antimonik, NIu; Beliak, NP; Manikhas, GM | 1 |
| Agostini, M; Bedin, C; Briarava, M; Del Bianco, P; Enzo, MV; Friso, ML; Lonardi, S; Maretto, I; Mescoli, C; Nitti, D; Pucciarelli, S; Toppan, P; Urso, E | 1 |
| Bhat, MK; Chaube, B; Pandey, V | 1 |
| Dechaphunkul, T; Pruegsanusak, K; Sangthawan, D; Sunpaweravong, P | 1 |
| Bergmann, ZP; Debus, J; Freier, K; Jensen, AD; Krauss, J; Münter, MW; Weichert, W | 1 |
| Bhat, MK; Sharma, A | 1 |
| Ha, SW; Kang, SB; Kim, HJ; Kim, JH; Kim, JW; Park, NH; Song, C; Song, S; Song, YS; Wu, HG | 1 |
| Brown, RJ; Gabrielson, E; Huso, DL; Jacobs, LK; Jeter, S; Khouri, NF; Kominsky, SL; Lange, JR; Mori, T; Powers, P; Rudek, MA; Stearns, V; Sukumar, S; Tarpinian, K; Tsangaris, TN; Yoshida, T; Zhang, Z | 1 |
| Fukunaga, K; Hirata, Y; Iida, H; Kakuno, A; Morita, M; Murata, S; Nishigami, T; Tamura, M; Tani, S; Yamanaka, N | 1 |
| Chera, B; Hayes, DN; Rosenberg, L; Rosenman, J; Shockley, W; Weissler, M; Zanation, A | 1 |
| Cheng, J; Mitchelson, K; Wang, L; Xie, F; Xing, W; Xu, Y | 1 |
| Knecht, R; Laban, S; Münscher, A; Schafhausen, P; Tribius, S; Wang, CJ | 1 |
| Katanyoo, K; Manusirivithaya, S; Sanguanrungsirikul, S | 1 |
| Jin, F; Li, B; Li, Y; Lv, M; Mao, X; Yao, F | 1 |
| Fukunaga, A; Hirano, G; Irie, M; Iwashita, H; Iwata, K; Kunimoto, H; Morihara, D; Sakamoto, M; Sakisaka, S; Sakurai, K; Shakado, S; Sohda, T; Takeyama, Y; Ueda, S; Yokoyama, K; Yotsumoto, K | 1 |
| Annino, DJ; Balboni, TA; Goguen, LA; Haddad, RI; Lorch, J; Norris, CM; Posner, MR; Sher, DJ; Thotakura, V; Tishler, RB | 1 |
| Chen, CM; Chen, S; Shao, ZM; Yu, KD; Zhou, RJ | 1 |
| Debus, J; Jensen, AD; Krauss, J; Lossner, K; Münter, MW; Nikoghosyan, AV; Potthoff, K; Simon, C | 1 |
| Bouchardy, C; Dehler, S; Ess, S; Frick, H; Joerger, M; Konzelmann, I; Savidan, A; Thürlimann, B | 1 |
| Blair, EA; Cohen, EEW; Haraf, DJ; List, M; Mouw, KW; Salama, JK; Solanki, AA; Stenson, KM; Vokes, EE; Witt, ME | 1 |
| Joseph, IB; Kelly, R; Michaelson, JS; Wortham, K; Yang, L; Zhang, X | 1 |
| Ellemann, AC; Kofoed, SC; Lundsgaard, M; Svendsen, LB | 1 |
| Coyle, C; Dyker, KE; Karakaya, E; Oksuz, DC; Prestwich, RJ; Sen, M; Yetmen, O | 1 |
| Kim, J; Kim, JH; Kim, JY; Kim, YS; Yoon, MS | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Demolin, G; Focan, C; Focan-Henrard, D; Graas, MP; Kreutz, F; Longrée, L; Moeneclaey, N | 1 |
| Bustam, AZ; Ng, CH; Phua, CE; Saad, M; Taib, NA; Teh, YC; Yip, CH; Yusof, MM | 1 |
| Cronin, EB; DeFusco, PA; Hart, J; Hegde, PU; Kane, M; Ricci, A; Tannenbaum, SH; Tavakoli, B; Xu, Y; Zhu, Q | 1 |
| Capitain, O; Cellier, P; Denis, F; Girault, S; Hamy, A; Mahé, MA; Mesgouez-Nebout, N; Paumier, A; Poirier, AL; Rousseau, D | 1 |
| Beukema, JC; Burgerhof, JG; Hospers, GA; Langendijk, JA; Muijs, CT; Mul, VE; Muller, K; Paardekooper, G; Plukker, JT; Smit, JK; Timmer, PR; van Dijk, BA; Woutersen, D | 1 |
| He, ZY; Hua, XD | 1 |
| Peerawong, T; Phungrassami, T; Pruegsanusak, K; Sangthong, R | 1 |
| Bischof, M; Debus, J; Huber, PE; Lindel, K; Muenter, MW; Roeder, F; Saleh-Ebrahimi, L; Zwicker, F | 1 |
| Durdux, C; Huguet, F; Lang, P; Monnier, L; St Guily, JL; Touboul, E | 1 |
| Gebhardt, BJ; Kirwan, J; McAfee, WJ; Mendenhall, CM; Mendenhall, WM; Morris, CG | 1 |
| Aslan, NM; Chee Ee Phua, V; Ismail, F; Kua, VF | 1 |
| Chen, CM; Li, JW; Liu, GY; Lu, JS; Shao, ZM; Shen, ZZ; Wu, J; Yu, KD | 1 |
| Chi, YH; Du, F; Jiang, WC; Song, Y; Sun, YK; Wang, JW; Yang, L; Zhou, AP | 1 |
| Chia, S; Cortés, J; Eniu, A; Harvey, V; Hegg, R; Hickish, T; McNally, V; Ratnayake, J; Ross, G; Schneeweiss, A; Seo, JH; Tausch, C; Tsai, YF | 1 |
| Lee, DW; Lee, HN; Lee, JW; Lee, KH; Park, JS; Park, ST | 1 |
| Butthongkomvong, K; Jhankumpha, S; Kumdang, S; Sirachainan, E; Sukhontharot, OU | 1 |
| Dumont, E; Johnson, AC; Oldenkamp, R; Sumpter, JP | 1 |
| Atsumi, K; Hirata, H; Honda, H; Matsumoto, K; Nakamura, K; Nonoshita, T; Ooga, S; Sasaki, T; Shioyama, Y; Uehara, S; Yoshitake, T | 1 |
| Bowman, A; Karam, I; Lee, C; Olson, R; Wilson, G; Wong, F | 1 |
| Chen, L; Feldman, LE; Garnett, A; Herman, LC; Smith, B; Spiotto, MT; Weichselbaum, RR | 1 |
| Fan, T; Fan, Z; Li, J; Lin, B; Ouyang, T; Wang, T; Xie, Y | 1 |
| Khemapech, N; Oranratanaphan, S | 1 |
| Bae, DS; Choi, CH; Huh, SJ; Kim, BG; Kim, TJ; Lee, JW; Lee, YY; Park, JY; Park, W; Yoon, A | 1 |
| Enomoto, T; Fujimoto, M; Fujita, M; Kanai, Y; Kim, A; Kimura, T; Matsuzaki, S; Morimoto, A; Nagamori, S; Naka, T; Serada, S; Ueda, Y; Yokoyama, T; Yoshino, K | 1 |
| Kalkanis, SN; Kim, EY; Kim, JK; Mikkelsen, T; Rock, J; Rosenblum, M; Ryu, S; Yechieli, R | 1 |
| Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G | 1 |
| Bruera, G; Cannita, K; Ficorella, C; Giordano, AV; Ricevuto, E; Vicentini, R | 1 |
| Blanchard, P; Bourhis, J; Daly-Schveitzer, N; Janot, F; Lévy, A; Tao, Y; Temam, S | 1 |
| Namikawa, K; Oashi, K; Omata, W; Tanaka, R; Tsutsumida, A; Yamamoto, Y; Yamazaki, N | 1 |
| Carver, JR; Liu, J; Manrique, C; Steingart, RM; Yadav, N | 1 |
| Jiang, Y; Yang, L; Yuan, Z; Zhang, Y; Zhao, Q | 1 |
| Beukema, JC; Burgerhof, JGM; de Groot, JW; Fiets, WE; Honing, J; Hospers, GAP; Legdeur, MJC; Muijs, CT; Muller, K; Paardekooper, G; Plukker, JTM; Slot, A; Smit, JK; Woutersen, D | 1 |
| Beloueche-Babari, M; Bhattacharya, B; Kamal Mustapa, N; Koh, KX; Loh, J; Low, SH; Soh, C; Soong, R | 1 |
| Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y | 1 |
| Endo, K; Ito, M; Kondo, S; Murono, S; Ueno, T; Wakisaka, N; Yoshizaki, T | 1 |
| Chen, D; Chen, J; Dou, J; Kai, C; Shi, F; Wang, J; Wang, X; Yang, C; Zhang, Y | 1 |
| Ando, M; Aogi, K; Fujiwara, Y; Hamano, T; Inoue, K; Iwata, H; Kuroi, K; Masuda, N; Ohono, S; Shimizu, S; Sukigara, T; Yamamoto, N; Yamauchi, H | 1 |
| Chinen, LT; D'Almeida Costa, F; da Costa, AA; de Lima, VC; Guimarães, AP; Lopes, CA; Ribeiro, AR | 1 |
| de Vries, EG; Hauptmann, M; Jonkers, J; Linn, SC; Lips, EH; Nederlof, PM; Rodenhuis, S; van Tinteren, H; Vd Vijver, MJ; Vollebergh, MA; Wesseling, J; Wessels, LF | 1 |
| Hasegawa, M; Imai, Y; Kirita, T; Kuniyasu, H; Kurihara, M; Sasahira, T; Shimomura, H; Shirone, N; Tamaki, S; Yamakawa, N; Yamanaka, Y | 1 |
| Boku, N; Furuse, J; Ishido, K; Kasuga, A; Machida, N; Morizane, C; Nishina, T; Okusaka, T; Sudo, K; Takahashi, H; Tobimatsu, K; Yamaguchi, T | 1 |
| Chen, CH; Chiang, PH; Shen, YC | 1 |
| Beohou, E; Bonnetain, F; Borg, C; Cleau, D; Demarchi, M; Dobi, E; Fein, F; Fiteni, F; Fratté, S; Jary, M; Kim, S; Monnien, F; Nerich, V; Nguyen, T; Pivot, X | 1 |
| Fury, MG; Koutcher, L; Lee, N; Morris, L; Pfister, DG; Riaz, N; Setton, J; Shapiro, LQ; Sherman, EJ; Shi, W; Wolden, SL; Zhang, Z | 1 |
| Arbea, L; Arredondo, J; Baixauli, J; Beorlegui, C; Cienfuegos, JA; Hernández-Lizoáin, JL; Pastor, C; Rotellar, F; Sola, JJ | 1 |
| Cheng, J; Jin, C; Liu, X; Liu, Y; Qi, X; Yang, J; Yu, D; Zhao, X | 1 |
| Adachi, S; Endo, I; Ichikawa, Y; Ishikawa, T; Kida, K; Narui, K; Sasaki, T; Satake, T; Shimada, K; Shimizu, D; Sugae, S; Tanabe, M; Yamada, A | 1 |
| Hayashi, N; Matsuo, T; Miyata, Y; Nomata, K; Ohba, K; Sakai, H; Sakamoto, I; Uetani, M | 1 |
| Chang, GJ; Crane, CH; Das, P; Eng, C; Ohinata, A; Pathak, P; Phillips, JK; Rodriguez-Bigas, M; Rogers, JE; Sethi, S; Vauthey, JN; Wolff, RA; Xing, Y; You, YN | 1 |
| Bijl, HP; Chouvalova, O; Christianen, ME; Doornaert, P; Langendijk, JA; Leemans, CR; Oosting, SF; Roodenburg, JL; Slotman, BJ; Steenbakkers, RJ; van der Laan, BF; van der Laan, HP; van der Schaaf, A; Verdonck-de Leeuw, IM; Wopken, K | 1 |
| Agüero, A; Farré, N; García, J; León, X; López, M; López-Pousa, A; Quer, M | 1 |
| Calkins, SM; Cinar, P; Kelley, RK; Venook, AP | 1 |
| Kim, HW; Kim, JH; Kim, JW; Lee, CG; Lee, IJ; Lee, YC; Park, H; Park, JJ; Youn, YH | 1 |
| Atanaskova Mesinkovska, N; Conic, RZ; Kiracofe, EA; Vidimos, AT | 1 |
| Aradi, J; Benkő, I; Géresi, K; Megyeri, A; Németh, J; Szabó, B; Szabó, Z | 1 |
| Autret, D; Capitain, O; Cellier, P; El Alouani, C; Gustin, P; Jadaud, É; Laccourreye, L; Peyraga, G; Pointreau, Y; Septans, AL; Tuchais, C; Vinchon-Petit, S; Yossi, S | 1 |
| Babacan, NA; Deveci, K; Kacan, T; Sancakdar, E; Seker, A; Seker, MM; Turesin, AK; Yilmaz, A | 1 |
| Fukuda, S; Furusawa, J; Hatakeyama, H; Homma, A; Kano, S; Mizumachi, T; Nakamaru, Y; Onimaru, R; Sakashita, T; Shirato, H; Terasaka, S; Tsuchiya, K; Yasuda, K; Yoshida, D | 1 |
| Chen, S; Di, GH; Jiang, YZ; Jin, X; Shao, ZM; Yu, KD | 1 |
| Doki, Y; Kurokawa, Y; Miyata, H; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M | 1 |
| Han, J; Li, R; Liang, J; Lin, Z; Liu, Y; Rao, Q; Xie, Q; Xie, X; Yao, T; Zhou, H | 1 |
| Breheret, R; Capitain, O; Laccourreye, L; Linot, B; Peyraga, G; Yossi, S | 1 |
| Ali-El-Dein, B; Babjuk, M; Burger, M; Chang, SS; Clayman, RH; Daneshmand, S; Efstathiou, JA; Fritsche, HM; Gakis, G; Galland, S; Hrbacek, J; Keegan, KA; Mischinger, J; Morgan, TM; Olugbade, K; Rink, M; Schubert, T; Stenzl, A; Thalmann, GN; Todenhöfer, T; Zaid, HB | 1 |
| Abdel-Aziz, NM; Abozeed, WN; Alsaleh, K; Alzahrani, A; Elbiomy, MA; Elsamany, S; Farooq, MU; Rasmy, A; Rawah, E | 1 |
| Berbée, M; Buijsen, J; Houben, R; Janssen, L; Lambin, P; Larue, R; Schraepen, MC; Sosef, M; Van De Voorde, L; Vanneste, B | 1 |
| Doornaert, P; Kaanders, JH; Terhaard, CH | 1 |
| Fleming, GF | 1 |
| Dartigues, P | 1 |
| Chang, GJ; Crane, CH; Das, P; Feig, BW; Krishnan, S; Minsky, BD; Rashid, A; Skibber, JM; Voong, KR; Wolff, RA; Yao, JC | 1 |
| Beukema, JC; Biermann, K; Bilgen, EJS; Blaisse, RJB; Bonenkamp, JJ; Busch, ORC; Creemers, GM; Cuesta, MA; Hospers, GAP; Hulshof, MCCM; Nieuwenhuijzen, GAP; Piet, AHM; Plukker, JTM; Punt, CJA; Reinders, JG; Rozema, T; Shapiro, J; Steyerberg, EW; Ten Kate, FJW; Tilanus, HW; van Berge Henegouwen, MI; van Dekken, H; van der Gaast, A; van der Sangen, MJC; van Hagen, P; van Laarhoven, HWM; van Lanschot, JJB; van Rij, CM; Verheul, HMW; Wijnhoven, BPL | 1 |
| Berg, S; Boessert, P; Fruth, K; Haxel, BR; Mann, WJ | 1 |
| Chao, Y; Chen, TJ; Hu, YW; Hung, YP; Huon, LK; Liu, CJ; Teng, CJ; Yang, MH; Yeh, CM | 1 |
| Bateman, E; Bowen, JM; Campbell, JM; Keefe, DM; Peters, MDj; Stephenson, MD | 1 |
| Astsaturov, IA; Berger, AC; Boland, PM; Burtness, BA; Cheng, JD; Cohen, SJ; Cooper, HS; Davey, M; Lebenthal, A; Meyer, JE; Neuman, T; Olszanski, AJ; Scott, WJ | 1 |
| Boupaijit, K; Suprasert, P | 1 |
| Coraggio, G; Delishaj, D; Fabrini, MG; Gadducci, A; Laliscia, C; Morganti, R; Paiar, F; Tana, R | 1 |
| Borel, C; Ciftci, S; Debry, C; Dupret-Bories, A; Schmaltz, H; Schultz, P; Takeda-Raguin, C | 1 |
| Dietrich, PY; Espeli, V; Hottinger, AF; Modarressi, A; Ruegg, E | 1 |
| Creemers, GJ; Kathiravetpillai, N; Koëter, M; Luyer, MD; Nieuwenhuijzen, GA; Rutten, HJ; van der Sangen, MJ | 1 |
| Ameri, A; Khoshbakht Ahmadi, H; Mortazavi, N; Novin, K | 1 |
| Clerici, E; Cozzi, L; D'Agostino, G; Fogliata, A; Franceschini, D; Franzese, C; Mancosu, P; Navarria, P; Scorsetti, M; Tomatis, S | 1 |
| Fong, CW | 1 |
| Cheah, SL; Chua, ML; Fong, KW; Kusumawidjaja, G; Shwe, MT; Soong, YL; Tan, SH; Tan, TW; Wee, JT | 1 |
| Bai, H; Cao, D; Chen, J; Sha, G; Shen, K; Wang, Y; Yang, J; Yuan, F; Zhang, Z | 1 |
| Alfieri, S; Bergamini, C; Bossi, P; Cavallo, A; Cova, A; Granata, R; Huber, V; Iacovelli, NA; Imbimbo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Resteghini, C; Rivoltini, L | 1 |
| Chang, CL; Chen, JH; Chen, TM; Lai, MT; Lee, FP; Lin, KC; Wu, CC; Wu, SY; Yen, YC; Yuan, KS | 1 |
| Cats, A; Jansen, EP; Sikorska, K; Snaebjornsson, P; van der Kaaij, RT; van Dieren, JM; van Sandick, JW; Voncken, FE | 1 |
| Barthélémy, P; Borel, C; Bronner, G; Burgy, M; Dupret-Bories, A; Flesch, H; Korenbaum, C; Lefevre, F; Truntzer, P | 1 |
| Bensch, KG; Dolan, JP; Haisley, KR; Hart, KD; Hunter, JG; Nabavizadeh, N; Schipper, PH; Thomas, CR; Vaccaro, GM | 1 |
| Bueno, R; Catalano, PJ; Enzinger, PC; Hong, TS; King, BL; Mamon, HJ; Martin, NE; Sanford, NN; Wo, JY | 1 |
| Chan, LP; Chen, JY; Chien, CY; Chu, PY; Hour, TC; Huang, CJ; Hung, CC; Lin, CS; Wang, YY; Wu, YJ; Yuan, SF | 1 |
| Albers, AE; Fichtner, I; Hoffmann, J; Keilholz, U; Klinghammer, K; Leser, U; Otto, R; Raguse, JD; Tinhofer, I | 1 |
| Baggio, R; Chavel, P; Darrieux, L; Safa, G; Tisseau, L | 1 |
| AbdelBaki, MS; Baskin, DS; Jones, J; Okcu, MF; Salceda, V; Stapleton, SL; Waguespack, SG | 1 |
| Alfonsi, M; Aupérin, A; Bardet, E; Bourhis, J; Calais, G; Deprez, P; Geoffrois, L; Gery, B; Graff, P; Grégoire, V; Lapeyre, M; Maingon, P; Martin, L; Pignon, T; Rives, M; Sire, C; Tao, Y; Verrelle, P | 1 |
| Aleman, BMP; Grootscholten, C; Sikorska, K; Snaebjornsson, P; van der Kaaij, RT; van Dieren, JM; van Sandick, JW; van Werkhoven, E; Voncken, FEM | 1 |
| Hiranyatheb, P; Jiarpinitnun, C; Ngamphaiboon, N; Pattaranutaporn, P; Sirachainun, E; Supsamutchai, C; Tamtai, A; Unwanatham, N | 1 |
| Balla, A; Bollo, J; Martinez, C; Quaresima, S; Rodriguez Luppi, C; Targarona, EM | 1 |
| Awada, A; Bergamini, C; Buter, J; Clement, PM; Fortpied, C; Licitra, LF; Menis, J; Remenar, E; Schrijvers, DL; Specenier, PM; Vermorken, JB | 1 |
| Katanyoo, K | 1 |
| Choi, YS; Jo, DY; Kim, JM; Ko, YB; Lee, HJ; Ryu, H; Song, IC; Yun, HJ | 1 |
| Borel, C; Burgy, M; Leblanc, J | 1 |
| Alehashem, M; Baniasadi, S | 1 |
| Fan, Y; He, Q; Liang, J; Liang, L; Luo, H; You, Y | 1 |
| Doosti-Irani, A; Haddad, P; Holakouie-Naieni, K; Mansournia, MA; Rahimi-Foroushani, A | 1 |
| Aitken, K; Athauda, A; Chau, I; Cunningham, D; Mohammed, K; Rao, S; Starling, N; Tait, D; Watkins, D | 1 |
| Huang, Q; Jiang, Y; Li, Q; Li, S; Liu, J; Wei, W; Yang, H | 1 |
| Fu, T; Gao, XZ; Guang, HJ | 1 |
| Ai, D; Badakhshi, H; Cao, J; Chen, Y; Deng, J; Fan, J; Fan, M; Huang, G; Li, J; Li, L; Li, Y; Lin, Q; Liu, Q; Luo, H; Ren, W; Wei, S; Wu, K; Yang, H; Ye, J; Zhang, J; Zhao, K; Zhao, W; Zheng, X; Zhou, J; Zhu, H; Zhu, Z | 1 |
| Bastit, V; Bon-Mardion, N; Clatot, F; Di Fiore, F; François, A; Jardin, F; Loeb, A; Manu, D; Marie, JP; Moldovan, C; Picquenot, JM; Rainville, V; Thureau, S | 1 |
| Blumenschein, GR; Garden, AS; Ginsberg, LE; Glisson, BS; Gold, KA; Haddad, RI; Hutcheson, K; Johnson, FM; Kies, MS; Lee, JJ; Lewis, J; Lin, HY; Massarelli, E; Myers, J; Papadimitrakopoulou, V; Pharaon, RR; Pickering, C; Rabinowits, G; Tishler, RB; William, WN; Williams, MD | 1 |
| Killock, D | 1 |
| Badoual, C; Bonfils, P; Fabre, E; Laccourreye, O; Lisan, Q; Marret, G; Oudard, S; Rubin, F | 1 |
| Griffiths, RJ; Hall, SF; Liu, FF; O'Sullivan, B | 1 |
| Fushimi, C; Hanyu, K; Katsube, Y; Kondo, T; Miura, K; Okada, T; Okamoto, I; Sato, H; Shimizu, A; Tsukahara, K | 1 |
| Babin, E; Bastit, V; Clatot, F; Di Fiore, F; Florescu, C; Gery, B; Moldovan, C; Rambeau, A; Roge, M; Thariat, J; Thureau, S | 1 |
| Namikawa, K; Takahashi, A; Tsutsui, K; Yamazaki, N | 1 |
| Asawapirom, U; Chaichompoo, W; Iempridee, T; Jantimaporn, A; Japrung, D; Khongkow, M; Khumkhrong, P; Namdee, K; Piboonprai, K; Pimtong, W; Suksamrarn, A | 1 |
| Bagot, M; Baroudjian, B; Basset-Seguin, N; Chapalain, M; Dupont, A; Lambert, J; Lebbe, C; Lhote, R | 1 |
| Lu, L; Wang, Y; Yang, L; Zhang, L | 1 |
| Baldwin, JR; Bryant, KB; Chen, E; Chin, S; He, S; Neil Hayes, D; Perez, RP; Shen, T; Shirai, K; Thaddeus Beck, J | 1 |
| Boku, N; Daiko, H; Hirano, H; Honma, Y; Inaba, K; Itami, J; Ito, Y; Iwasa, S; Kanamori, J; Kato, K; Murakami, N; Nagashima, K; Oguma, J; Okita, N; Shoji, H; Takashima, A | 1 |
| Komori, K; Kurata, T; Minami, K; Nakamura, T; Saito, S; Sakashita, K; Uchida, E; Watanabe, T; Yanagisawa, R | 1 |
| Broeks, A; Cimino-Mathews, A; Daletzakis, A; de Boo, L; Hooijberg, E; Horlings, HM; Kok, M; Linn, S; Loncova, Z; Lubeck, Y; Opdam, M; Rieder, D; Sanders, J; Sobral-Leite, M; Trajanoski, Z; van de Vijver, K; van der Wiel, R; van Rossum, A; van Tinteren, H; Vollebergh, M | 1 |
| Ebrahim, F; Ekheden, I; Henriksson, R; Ólafsdóttir, H; Raaschou, P; Wettermark, B; Ye, W | 1 |
| Hamauchi, S; Kawakami, T; Mori, K; Ogawa, H; Onitsuka, T; Onoe, T; Onozawa, Y; Shirasu, H; Yokota, T | 1 |
| Chan, FSY; Chan, WWL; Kwong, DLW; Lam, KO; Law, SYK; Wong, CLY; Wong, IYH; Zhang, RQ | 1 |
| Alizadeh, M; Ayad, T; Bahig, H; Bélair, M; Bissada, E; Christopoulos, A; Filion, E; Guertin, L; Lambert, L; Nguyen-Tan, PF; Soulières, D | 1 |
| Doi, K; Fumita, S; Haratani, K; Hayashi, H; Ishikawa, K; Iwasa, T; Kanemura, H; Kitano, M; Kurosaki, T; Mitani, S; Nakagawa, K; Nishimura, Y; Otsuki, N; Suzuki, S; Tanaka, K; Yoshida, T | 1 |
| Borg, C; Kim, S; Vernerey, D | 1 |
| Rao, S | 1 |
| Brar, S; Brierley, J; Chan, BA; Chen, EX; Darling, G; Elimova, E; Espin-Garcia, O; Hafezi-Bakhtiari, S; Jang, RW; Jiang, DM; Kim, J; Knox, JJ; Lim, CH; Liu, G; Moignard, S; Natori, A; Ringash, J; Rogalla, P; Sim, HW; Swallow, CJ; Wong, R | 1 |
| Bidard, FC; Borg, C; Cabel, L; Kim, S; Spehner, L | 1 |
| Chan, YS; Chen, FW; Chen, PS; Cheng, TL; Feng, SY; Hsu, HP; Hung, JH; Jiang, JZ; Lai, MD; Lin, FP; Liu, YW; Omar, HA; Phan, NN; Sun, Z; Wang, CY; Yeh, PH; Yen, MC | 1 |
| Barsky, AR; Ben-Josef, E; Dreyfuss, AD; Eads, JR; Karasic, TB; Kucharczuk, JC; Metz, JM; Plastaras, JP; Wileyto, EP; Williams, NN; Wojcieszynski, AP | 1 |
| Amorim, C; Domingues, I; Felix, R; Garcia, AR; João Sousa, M; Mariano, M; Pontes, F; Salgueiro, F; Teixeira, M | 1 |
| Damghani, MA; Larizadeh, MH; Mohammadi, F; Shabani, M | 1 |
| Estrada-Muñiz, E; Galot-Linaldi, J; Hernández-Sánchez, KM; Vega, L | 1 |
| Bekaii-Saab, T; Boffa, DJ; Frankel, WL; Fruth, B; Goodman, KA; Hall, NC; Ilson, DH; Janjigian, YY; Meyerhardt, JA; Meyers, MO; Mitchell, K; Niedzwiecki, D; Noonan, A; O'Reilly, EM; Ou, FS; Thurmes, PJ; Twohy, E; Venook, AP | 1 |
| Bai, C; Chang, X; Chen, W; Feng, J; Ge, M; Guo, Y; He, X; Huang, X; Li, Z; Lin, T; Liu, Y; Luo, Y; Shen, L; Sun, Y; Wang, L; Xue, K; Yang, K; Zeng, Y; Zhang, Q; Zhu, X | 1 |
| Chang, HK; Chao, YK; Chen, HW; Chiang, PC; Hsieh, JC; Hung, TM; Kuo, YC; Liu, HL; Peng, MT; Su, PJ; Wang, HM; Wen, CT; Wu, MH | 1 |
| Bissoli, NS; Bonela, LAS; Gonçalves, WL; Gouvea, SA; Menezes, BC; Oliveira, KG; Sartorio, CL; Thebit, MM | 1 |
| Al-Jumayli, M; Al-Obaidi, A; Bansal, A; Baranda, J; Choucair, K; Park, R; Saeed, A; Sun, W | 1 |
| Endo, S; Fujiwara, Y; Higashida, M; Iwamoto, R; Katada, Y; Kinoshita, S; Kitagawa, S; Kubota, H; Mineta, S; Okada, T; Sanuki, F; Tanaka, H; Ueno, M; Ueno, T; Yoshimatsu, K | 1 |
| Barambo-Wagner, ML; Lohan-Codeço, M; Meireles Da Costa, N; Nasciutti, LE; Palumbo, A; Ribeiro Pinto, LF | 1 |
| Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
| Enzinger, PC; Guo, H; Joo, S; Meng, Y; Qu, T; Zhang, S; Zhong, Y | 1 |
| Adams, A; Baues, C; Celik, E; Linde, P; Mallmann, M; Marnitz, S; Rosenbrock, J; Trommer, M; Wegen, S | 1 |
| Chen, LM; Chien, LY; Fu, CK; Lee, HL | 1 |
| Bonomo, P; Borcoman, E; Cau, MC; Depenni, R; Ghi, MG; Ghiani, M; Le Tourneau, C; Leo, L; Messinger, D; Montesarchio, V; Ronzino, G; Salmio, S; Sbrana, A; Schulten, J | 1 |
| Choueiri, MA; Dietz, MD; Zelmanski, MH | 1 |
| Nakano, E; Namikawa, K; Ogata, D; Wada, S; Yamazaki, N | 1 |
45 review(s) available for fluorouracil and carboplatin
| Article | Year |
|---|---|
[Chemotherapy for advanced pancreatic carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Fluorouracil; Humans; Mitomycin; Mitomycins; Pancreatic Neoplasms; Streptozocin | 1992 |
[The status of sequential chemo-/radiotherapy in inoperable head and neck cancers. Personal results and review of the literature].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Survival Rate | 1991 |
[New trends in antineoplastic drug research].
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carboplatin; Danazol; Fluorouracil; Folic Acid; Harringtonines; Humans; Organoplatinum Compounds; Quinazolines; Thymine Nucleotides | 1985 |
The role of paclitaxel in the treatment of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiotherapy, Adjuvant; Tumor Cells, Cultured | 1995 |
[Predictive value of the hemogram for myelotoxicity induced by the association of carboplatin-fluorouracil on the 4th day of the therapeutic regimen].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinoma, Squamous Cell; Fluorouracil; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Retrospective Studies; Time Factors | 1996 |
Remission of recurrent mixed germ cell tumor of the ovary after treatment with vincristine, carboplatin, fluorouracil, and ifosfamide: a case report and review of the literature.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Female; Fluorouracil; Germinoma; Humans; Ifosfamide; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Vincristine | 1996 |
[Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Drug Combinations; Fluorouracil; Humans; Lung Neoplasms; Tegafur; Uracil | 1996 |
[Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Skin Neoplasms; Sweat Gland Neoplasms; Vincristine | 1997 |
New cytostatic agents for the treatment of head and neck cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids | 1997 |
[Chemoradiotherapy for patients with advanced head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1997 |
[Treatment for recurrent head and neck carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Combined Modality Therapy; Epirubicin; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage | 1998 |
[Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Neoplasm Invasiveness; Radiotherapy Dosage; Treatment Outcome; Urinary Bladder Neoplasms | 1998 |
[Continuous radiosensitizing chemotherapy].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Nutritional Support; Radiation-Sensitizing Agents; Rectal Neoplasms | 1999 |
Taxol in the management of cancers of the breast and the ovary.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Ovarian Neoplasms; Paclitaxel; Prognosis | 2000 |
Pharmacokinetically guided administration of chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Busulfan; Carboplatin; Cisplatin; Etoposide; Fluorouracil; Humans; Topotecan | 2000 |
Randomized trials of high dose chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Randomized Controlled Trials as Topic; Survival Analysis; Thiotepa | 2001 |
[Preclinical studies of oxaliplatin in combination chemotherapy].
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Fluorouracil; Gemcitabine; Humans; Mice; Models, Biological; Organoplatinum Compounds; Oxaliplatin; Tumor Cells, Cultured | 2001 |
Invasive bladder cancer: organ preservation by radiochemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Fluorouracil; Humans; Life Tables; Lymphatic Metastasis; Male; Middle Aged; Mucous Membrane; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Radiation-Sensitizing Agents; Salvage Therapy; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2002 |
Platinum compounds in the treatment of advanced breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Mastectomy; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Preoperative Care; Severity of Illness Index; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lung; Prognosis; Radiation Pneumonitis; Respiratory Function Tests; Risk Factors | 2002 |
Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carboplatin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Life Tables; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2004 |
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[Decision making in non resectable head and neck tumours].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Decision Making; Fluorouracil; Forecasting; Head; Head and Neck Neoplasms; Humans; Meta-Analysis as Topic; Mitomycin; Mouth; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Randomized Controlled Trials as Topic | 2005 |
Revisiting induction chemotherapy for head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Paclitaxel; Taxoids | 2005 |
Docetaxel in the management of advanced pancreatic cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carboplatin; Chemotherapy, Adjuvant; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Fluorouracil; Gemcitabine; Humans; Irinotecan; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Taxoids; Thalidomide | 2005 |
Hepatoblastoma: an oncological review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fluorouracil; Hepatoblastoma; Humans; Liver Neoplasms; Survival Analysis; Vincristine | 2006 |
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Mitomycin; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2006 |
[Progress in the treatment of gastrointestinal cancers due to introduction of neoadjuvant concept].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Remission Induction; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2006 |
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Circadian Rhythm; Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Time Factors | 2007 |
[Primary clear cell carcinoma of the cervix: report of five cases and review of the literature].
Topics: Adenocarcinoma, Clear Cell; Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cervix Uteri; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms | 2008 |
Molecularly targeted agents in the treatment of recurrent or metastatic squamous cell carcinomas of the head and neck.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Delivery Systems; Fluorouracil; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Taxoids; Time Factors | 2008 |
Trastuzumab emtansine, an antibody-drug conjugate for the treatment of HER2+ metastatic breast cancer.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Clinical Trials as Topic; Docetaxel; Female; Fluorouracil; Genes, erbB-2; Humans; Immunoconjugates; Maytansine; Mice; Mice, SCID; Receptor, ErbB-2; Taxoids; Trastuzumab | 2010 |
Molecular targeting agents in the context of primary chemoradiation strategies.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Disease Progression; ErbB Receptors; Fluorouracil; Head and Neck Neoplasms; Humans; Molecular Targeted Therapy; Oropharyngeal Neoplasms; Paclitaxel; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2013 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine | 2013 |
Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carboplatin; Cardiovascular Diseases; Cisplatin; Female; Fluorouracil; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Male; Myocardial Ischemia; Neoplasms; Practice Guidelines as Topic; Protein-Tyrosine Kinases; Radiotherapy; Risk Factors; Survivors; Trastuzumab; Ventricular Dysfunction, Left | 2013 |
[Adjuvant treatment for esophagogastric junction cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asia; Capecitabine; Carboplatin; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Digestive System Surgical Procedures; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophagogastric Junction; Europe; Fluorouracil; Humans; Lymph Node Excision; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Taxoids; Tegafur | 2015 |
Second-Line Therapy for Endometrial Cancer: The Need for Better Options.
Topics: Adenocarcinoma; Amines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Fluorouracil; Gabapentin; gamma-Aminobutyric Acid; Humans; Medical Oncology; Middle Aged; Paclitaxel; Receptors, Progesterone; Rectal Neoplasms; Stroke; TOR Serine-Threonine Kinases; Treatment Outcome | 2015 |
[Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carboplatin; Combined Modality Therapy; Cystadenofibroma; Diagnosis, Differential; Female; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Parenteral; Irinotecan; Leucovorin; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Oxaliplatin; Paclitaxel; Pemetrexed; Peritoneal Neoplasms | 2015 |
Fluoropyrimidine and platinum toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Fluorouracil; Humans; Meta-Analysis as Topic; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Polymorphism, Genetic; Systematic Reviews as Topic | 2016 |
Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Cushing Syndrome; Female; Fluorouracil; Humans; Leucovorin; Pituitary Neoplasms | 2017 |
Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?
Topics: Antineoplastic Agents, Phytogenic; Carboplatin; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2018 |
A network meta-analysis of the treatments for esophageal squamous cell carcinoma in terms of survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Network Meta-Analysis; Paclitaxel; Survival Analysis | 2018 |
[Squamous cell anal carcinoma. What's next ?]
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Contraindications, Drug; DNA, Viral; Fluorouracil; Humans; Immune Checkpoint Inhibitors; Immunity, Cellular; Neoplasm Recurrence, Local; Paclitaxel; Telomerase | 2021 |
Molecular mechanisms associated with chemoresistance in esophageal cancer.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carboplatin; Cisplatin; Drug Resistance, Neoplasm; Esophageal Neoplasms; Fluorouracil; Humans; Molecular Targeted Therapy; Mutation; Paclitaxel; Tumor Microenvironment | 2022 |
167 trial(s) available for fluorouracil and carboplatin
| Article | Year |
|---|---|
Neoadjuvant combination of carboplatin and 5-FU in head and neck cancer: a randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Middle Aged; Survival Rate | 1992 |
Therapy of patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Leukocytes, Mononuclear; Middle Aged | 1992 |
Carboplatin (CBDCA), 5-fluorouracil (5-FU) and mitoxantrone (DHAD): an effective and well tolerated regimen for metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Evaluation; Female; Fluorouracil; Humans; Middle Aged; Mitoxantrone; Neoplasm Metastasis | 1992 |
Negative phase II study with carboplatin and 5-fluorouracil in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis | 1992 |
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Logistic Models; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome | 1992 |
[Palliative chemotherapy of epidermoid carcinoma of the upper respiratory and digestive tracts with a combination of carboplatin and 5-fluorouracil].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Palliative Care; Respiratory Tract Neoplasms; Time Factors | 1990 |
Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Retrospective Studies | 1991 |
Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Health Planning Guidelines; Humans; Male; Middle Aged | 1991 |
A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycins; Pancreatic Neoplasms; Streptozocin | 1991 |
[The status of sequential chemo-/radiotherapy in inoperable head and neck cancers. Personal results and review of the literature].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Survival Rate | 1991 |
A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate | 1991 |
Intracavitary chemotherapy.
Topics: Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorubicin; Etoposide; Fluorouracil; Humans; Immunotherapy; Infusions, Parenteral; Melphalan; Methotrexate; Mitomycins; Mitoxantrone; Neoplasms; Organoplatinum Compounds | 1986 |
High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Ovarian Neoplasms; Survival Rate | 1995 |
The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Graft Survival; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Male; Melphalan; Methotrexate; Middle Aged; Neoplasms; Neutropenia; Salvage Therapy; Treatment Outcome | 1993 |
Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Treatment Outcome | 1995 |
Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Remission Induction; Survival Rate | 1995 |
Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Interferon-gamma; Interleukin-2; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Mitomycin; Necrosis; Pilot Projects; Spleen; Survival Rate; Tomography, Emission-Computed | 1995 |
A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Remission Induction; Stomatitis; Survival Analysis | 1995 |
[Hepatic arterial infusion therapy for gastric liver metastasis using implanted reservoir].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1995 |
Palliative intra-arterial (i.a.) chemotherapy with carboplatin (CBDCA) and 5-FU in unresectable advanced (stage III and IV) head and neck cancer using implantable port-systems.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Drug Delivery Systems; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Palliative Care | 1995 |
[Preliminary results of a prospective randomized study of primary chemotherapy in carcinoma of the oral cavity and pharynx].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Adjuvant; Treatment Outcome | 1995 |
Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Remission Induction | 1995 |
[Home chemotherapy for peritoneal carcinomatosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Home Care Services, Hospital-Based; Home Infusion Therapy; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms | 1994 |
A phase 1-2 trial of superselective carboplatin, low-dose infusional 5-fluorouracil and concurrent radiation for high-grade gliomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Female; Fluorouracil; Glioblastoma; Humans; Infusions, Intravenous; Male; Middle Aged; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome | 1995 |
[Cisplatin/5-FU versus carboplatin/5-FU. 5 year follow-up].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Rate | 1994 |
Radiation and chemotherapy. Treatment of localized pancreatic carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Radiotherapy, High-Energy; Retrospective Studies; Streptozocin; Survival Rate | 1994 |
Carboplatin in combination as first-line therapy in advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neutropenia; Thrombocytopenia | 1993 |
Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Mouth Neoplasms; Pharyngeal Neoplasms; Prospective Studies | 1993 |
Combined chemo-radiotherapy with carboplatin, 5-fluorouracil and folinic acid for cancer of the urinary bladder: acute and late side effects.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Radiotherapy Dosage; Survival Rate; Urinary Bladder Neoplasms | 1993 |
Intra-arterial hepatic treatment with carboplatin (CBDCA) and 5-fluorouracil (5-FU) in metastases from colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Colorectal Neoplasms; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Survival Analysis | 1993 |
High-dose carboplatin and mitoxantrone with autologous bone marrow support in the treatment of advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Survival Analysis; Transplantation, Autologous | 1993 |
Ambulatory chronotherapy with 5-fluorouracil, folinic acid, and carboplatin for advanced non-small cell lung cancer. A phase II feasibility trial.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chronobiology Phenomena; Feasibility Studies; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged | 1995 |
[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Oligopeptides; Placebos | 1995 |
Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis | 1996 |
Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Nasopharyngeal Neoplasms; Prospective Studies; Radiotherapy Dosage | 1996 |
Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group study.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Patient Compliance; Survival Analysis | 1996 |
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Glutamine; Humans; Ifosfamide; Male; Neoplasms; Pilot Projects; Placebos; Sarcoma, Kaposi; Stomatitis; Vincristine | 1996 |
[Systemic neoadjuvant chemotherapy in advanced head and neck tumors: a randomized study of the combination of 5-FU/carboplatin versus 5-FU/cisplatin].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Randomized Controlled Trials as Topic | 1996 |
Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Female; Fluorouracil; Humans; Karnofsky Performance Status; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Survival Rate | 1996 |
Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chi-Square Distribution; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Uterine Cervical Neoplasms | 1996 |
[Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 1996 |
Carboplatin, 5-fluorouracil and folinic acid: a 48-hour chemotherapy regimen in advanced and recurrent squamous carcinoma of the head and neck.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 1996 |
A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Quality of Life; Survival Rate; Treatment Outcome | 1997 |
Intra-arterial chemotherapy followed by chemo-embolisation in unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Survival Rate | 1997 |
Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Retreatment; Survival Rate | 1997 |
Carboplatin and 5-fluorouracil in squamous cell carcinoma of the head and neck previously responding to cisplatin and 5-fluorouracil.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged | 1997 |
Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carboplatin; Female; Fluorouracil; Humans; Leucovorin; Lomustine; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis; Vinblastine; Vinorelbine | 1997 |
First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Rate; Treatment Outcome | 1996 |
Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Fluorouracil; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1997 |
Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: correlation with clinical responses.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytokines; Cytotoxicity, Immunologic; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Neoplasms | 1997 |
A new in vitro assay for quantitation of chemotherapy-induced mucositis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Epithelium; Female; Fluorouracil; Humans; Male; Microscopy, Fluorescence; Middle Aged; Mouth Mucosa; Staining and Labeling; Stomatitis; Thiotepa | 1997 |
[Multicentric prospective, randomized study of the role of filgrastim (G-CSF) after transplant of hematopoietic progenitor cells mobilized with G-CSF in patients with cancer of the breast].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neutropenia; Prospective Studies; Recombinant Proteins; Thiotepa | 1997 |
Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Treatment Outcome | 1997 |
Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: distant metastasis and local recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Survival Rate; Time Factors | 1998 |
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carboplatin; Cholangiocarcinoma; Drug Interactions; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms | 1998 |
A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Salvage Therapy | 1998 |
Squamous cell granulomas of the neck: histologic regression of metastatic squamous cell carcinoma following chemotherapy and/or radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Culture Techniques; Diagnosis, Differential; Female; Fibrosis; Fluorouracil; Granuloma, Foreign-Body; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Registries; Remission Induction; Tirapazamine; Triazines | 1998 |
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Estrogen Antagonists; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Rate; Tamoxifen; Thiotepa | 1998 |
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic cooperative oncology group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Drug Synergism; Endometrial Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 1999 |
Carboplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up.
Topics: Adult; Aged; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 1998 |
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.
Topics: Adenine; Adult; Aged; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Imides; Isoquinolines; Melphalan; Middle Aged; Naphthalimides; Neoplasm Staging; Organophosphonates; Prospective Studies; Survival Analysis; Trimetrexate | 1999 |
The role of stable disease in objective response assessment and its impact on survival in advanced colorectal cancer: is "stable disease" a homogenous response category?
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Prognosis; Prospective Studies; Survival Analysis; Time Factors | 1999 |
Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Analysis; Uterine Cervical Neoplasms | 1999 |
[Results of a prospective randomized trial with induction chemotherapy for cancer of the oral cavity and tonsils].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Fluorouracil; Humans; Lymphatic Metastasis; Mouth Neoplasms; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Radiotherapy, Adjuvant; Tonsillar Neoplasms | 1999 |
[Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
Topics: Adult; Aged; Amifostine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cytoprotection; Fluorouracil; Head and Neck Neoplasms; Humans; Middle Aged; Mouth Mucosa; Postoperative Care; Preoperative Care; Radiation-Protective Agents; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Stomatitis; Time Factors | 1999 |
Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome | 1999 |
Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronotherapy; Colorectal Neoplasms; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Leucovorin; Male; Middle Aged; Survival Rate; Treatment Outcome | 2000 |
Intra-arterial chemotherapy for unresectable pancreatic cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Pain; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome | 2000 |
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
Topics: Acute Disease; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Proportional Hazards Models; Sweden; Thiotepa | 2000 |
Neoadjuvant therapy for organ preservation in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Leucovorin; Male; Middle Aged; Oropharyngeal Neoplasms; Radiotherapy Dosage; Survival Analysis | 2000 |
Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Interactions; Endothelial Growth Factors; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Lymphokines; Male; Middle Aged; Neoplasms; Paclitaxel; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
A randomized Phase II trial in patients with carcinoma of an unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome | 2001 |
Infusional ECarboF in patients with advanced breast cancer: a very active and well-tolerated out-patient regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Neutropenia | 2000 |
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukocytes; Lymphatic Metastasis; Middle Aged; Platelet Count; Recombinant Proteins; Telomerase; Telomere; Thiotepa | 2001 |
Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.
Topics: Alpha Rhythm; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Cyclophosphamide; Depression; Electroencephalography; Epirubicin; Event-Related Potentials, P300; Evoked Potentials; Fatigue; Fluorouracil; Humans; Intelligence; Least-Squares Analysis; Middle Aged; Neuropsychological Tests; Thiotepa | 2001 |
[Dose-intensive chemotherapy with continuous infusion 5-fluorouracil].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Neoplasms; Time Factors | 1999 |
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Germany; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Life Tables; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Prognosis; Proportional Hazards Models; Prospective Studies; Radiotherapy, High-Energy; Survival Analysis; Treatment Outcome | 2001 |
Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome | 2001 |
Response and progression in recurrent malignant glioma.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Alitretinoin; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Eflornithine; Female; Fluorouracil; Glioblastoma; Glioma; Humans; Interferon-beta; Male; Menogaril; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Proportional Hazards Models; Texas; Treatment Outcome; Tretinoin | 1999 |
[The combined therapy of carboplatin, fluorouracil and radiotherapy for moderate and advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 1999 |
Chronotherapy of colorectal cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chronotherapy; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Mice; Organoplatinum Compounds; Oxaliplatin; Radiotherapy, Adjuvant; Rats | 2002 |
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farbe
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Estrogens; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Life Tables; Melphalan; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Progesterone; Prognosis; Proportional Hazards Models; Remission Induction; Survival Analysis; Thiotepa; Time Factors; Treatment Outcome | 2002 |
Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Radiotherapy Dosage; Radiotherapy, High-Energy; Survival Analysis | 2002 |
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Hepatoblastoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Metastasis; Survival Rate; Vincristine | 2002 |
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome | 2003 |
[Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphocyte Count; Male; Mitomycin; Moxibustion; Phytotherapy; Stomach Neoplasms; T-Lymphocyte Subsets | 2002 |
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Neutropenia; Pain; Palliative Care; Pancreatic Neoplasms; Stomach Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome; Weight Loss | 2003 |
[Randomised study to evaluate the chronotolerance of a combination infusional chemotherapy with 5-fluorouracil, folinic acid and carboplatin in non small cell lung cancer (NSCLC) patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chronotherapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2003 |
First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiation-Sensitizing Agents; Survival Rate | 2003 |
Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Image; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Emotions; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Middle Aged; Patient Satisfaction; Peripheral Blood Stem Cell Transplantation; Quality of Life; Thiotepa | 2003 |
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Prognosis | 2004 |
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Prospective Studies; Salvage Therapy | 2004 |
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome | 2004 |
Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Survival Rate; Weight Loss | 2004 |
Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Drug Administration Schedule; Endpoint Determination; Female; Fluorouracil; Humans; Male; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Platinum; Stomach Neoplasms | 2005 |
[Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronobiology Phenomena; Colonic Neoplasms; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms; Survival Analysis | 2005 |
[Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chronobiology Phenomena; Cohort Studies; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Middle Aged | 2005 |
[Adjuvant chemotherapy for Dukes B2 and C colon cancer combining 5-fluorouracil and folinic acid with or without carboplatin. Feasibility and comparison between standard and chronomodulated deliveries].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronobiology Phenomena; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged | 2005 |
Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Carboplatin; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Stomach Neoplasms; Taxoids | 2005 |
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Dose Fractionation, Radiation; Esophageal Stenosis; Female; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Salvage Therapy; Survival Rate; Taxoids | 2005 |
Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hemoglobin A; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Prognosis; Regression Analysis; Survival Analysis; Treatment Outcome | 2006 |
Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Karnofsky Performance Status; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms | 2006 |
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Radiotherapy Dosage; Remission Induction; Taxoids | 2006 |
Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 2006 |
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Male; Vincristine | 2006 |
[Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Proportional Hazards Models; Remission Induction; Survival Rate | 2006 |
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Radiotherapy Dosage | 2007 |
Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Taxoids | 2007 |
Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Organoplatinum Compounds; Survival Rate | 2007 |
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Prospective Studies; Thiotepa | 2007 |
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.
Topics: Abdominal Neoplasms; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Carcinoembryonic Antigen; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Neutropenia; Treatment Outcome | 2007 |
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Analysis; Taxoids | 2007 |
A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Feasibility Studies; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome | 2008 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Neoplasm Staging; Paclitaxel; Patient Selection; Radiotherapy; Recurrence; Survival Analysis; Survivors; Time Factors | 2007 |
Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Longitudinal Studies; Menopause; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Quality of Life; Risk Factors; Tamoxifen; Thiotepa; Transplantation, Autologous | 2007 |
Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Pain; Pancreatic Neoplasms; Prognosis; Survival Rate | 2008 |
Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome | 2007 |
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Remission Induction | 2008 |
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Topics: Aged; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease Progression; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Thrombocytopenia | 2008 |
[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Staging; Paclitaxel; Radioisotope Teletherapy; Survival Rate; Uterine Cervical Neoplasms | 2008 |
Long-term survival following chemoradiation for inoperable non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Survival Rate | 2008 |
Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel | 2008 |
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Gefitinib; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Quinazolines; Remission Induction; Taxoids; Treatment Outcome | 2009 |
Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Longitudinal Studies; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Survival Rate; Thrombocytopenia; Treatment Outcome | 2010 |
Phase I study of capecitabine, carboplatin and intensity-modulated radiation therapy for head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Head and Neck Neoplasms; Humans; Treatment Outcome | 2009 |
beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Taxoids; Treatment Outcome; Tubulin | 2009 |
Chemotherapy alone for organ preservation in advanced laryngeal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome | 2010 |
Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin versus 5-fluorouracil plus carboplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Survival Rate; Taxoids; Thrombocytopenia; Vomiting | 2010 |
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Quality of Life; Survival Rate; Treatment Outcome | 2010 |
Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; ROC Curve; Treatment Outcome | 2010 |
A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Heme; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Prospective Studies; Radiation-Protective Agents; Stomatitis; Treatment Outcome | 2010 |
Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemotherapy, Adjuvant; Disease-Free Survival; Fluorouracil; Germany; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Laryngeal Neoplasms; Oropharyngeal Neoplasms; Otorhinolaryngologic Neoplasms; Prospective Studies; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Time Factors; Treatment Outcome | 2010 |
Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Endostatins; Female; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Recombinant Proteins; Survival Rate; Taxoids; Treatment Outcome | 2010 |
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Carboplatin; Carcinoma, Basal Cell; Comparative Genomic Hybridization; Cyclophosphamide; DNA Methylation; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Mutation; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Thiotepa; Treatment Outcome | 2011 |
Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Radiotherapy Dosage; Severity of Illness Index; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids; Time Factors | 2011 |
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms | 2011 |
Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.
Topics: Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Conformal; Young Adult | 2011 |
Preclinical and clinical evaluation of intraductally administered agents in early breast cancer.
Topics: Adult; Animals; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Doxorubicin; Drug Administration Routes; Female; Fluorouracil; Humans; Mammary Glands, Animal; Mammary Neoplasms, Animal; Methylnitrosourea; Paclitaxel; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Young Adult | 2011 |
Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Grading; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck | 2012 |
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Female; Fluorouracil; Humans; Hydroxyurea; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Quality of Life; Risk Factors; Time Factors; Treatment Outcome | 2012 |
Phase I - II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Colorectal Neoplasms; Disease Progression; Drug Chronotherapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Middle Aged; Treatment Outcome | 2013 |
Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Retrospective Studies; Survival; Treatment Outcome | 2013 |
Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressive HER2-positive breast cancers, especially in luminal-B subtype, compared with a once-every-3-weeks schedule.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Receptor, ErbB-2; Remission Induction; Trastuzumab; Treatment Outcome | 2013 |
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Heart; Humans; Inflammatory Breast Neoplasms; Neoadjuvant Therapy; Receptor, ErbB-2; Stroke Volume; Taxoids; Trastuzumab; Ventricular Function, Left | 2013 |
Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Teratoma | 2013 |
Effectiveness and safety of intensive triplet chemotherapy plus bevacizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer patients.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Carboplatin; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Demography; DNA Mutational Analysis; Dose-Response Relationship, Drug; Female; Fluorouracil; Genotype; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Organoplatinum Compounds; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Treatment Outcome | 2013 |
[ATP-tumor chemosensitivity assay directed chemotherapy in patients with cervical cancer].
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Neoplasm Recurrence, Local; Paclitaxel; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 2013 |
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Receptor, ErbB-2; Treatment Outcome | 2014 |
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; Prognosis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2014 |
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Paclitaxel | 2015 |
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorouracil; Humans; Middle Aged; Molecular Targeted Therapy; Paclitaxel; Piperidines; Quinazolines; Treatment Outcome | 2017 |
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease Progression; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2017 |
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Taxoids; Young Adult | 2017 |
Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; China; Cisplatin; Clinical Trials as Topic; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Multicenter Studies as Topic; Paclitaxel; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2018 |
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Squamous Cell Carcinoma of Head and Neck | 2019 |
Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studies.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cetuximab; Cisplatin; Drug Interactions; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms | 2019 |
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphocytes, Tumor-Infiltrating; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Thiotepa; Triple Negative Breast Neoplasms | 2020 |
Phase II study of de-intensified intensity-modulated radiotherapy and concurrent carboplatin/5-fluorouracil in lateralized p16-associated oropharyngeal carcinoma.
Topics: Carboplatin; Carcinoma, Squamous Cell; Fluorouracil; Humans; Oropharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2020 |
Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Immune Checkpoint Inhibitors; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2021 |
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Oxaliplatin; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Young Adult | 2021 |
First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; China; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Squamous Cell Carcinoma of Head and Neck; Time Factors | 2021 |
353 other study(ies) available for fluorouracil and carboplatin
| Article | Year |
|---|---|
Cytoreductive combination chemotherapy for regionally advanced unresectable extramammary Paget carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fluorouracil; Humans; Immunohistochemistry; Leucovorin; Male; Paget Disease, Extramammary | 1992 |
Effect of WR-2721 on the toxicity and antitumor activity of the combination of carboplatin and 5-fluorouracil.
Topics: Amifostine; Anemia; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Female; Fluorouracil; Leukopenia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Random Allocation; Thrombocytopenia; Weight Loss | 1992 |
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Transplantation; Humans; Macrophages; Methotrexate; Middle Aged; Neoplasm Metastasis; Thiotepa | 1992 |
Influence of chemotherapy on hormone receptor concentration in a xenotransplanted endometrial cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Mice; Mice, Nude; Mitomycins; Neoplasm Transplantation; Receptors, Estradiol; Receptors, Progesterone; Transplantation, Heterologous | 1992 |
[The ototoxicity of the cytostatic drug carboplatin in patients with head-neck tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Conduction; Carboplatin; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Hearing Loss, Sensorineural; Humans; Middle Aged | 1992 |
Carboplatin plus 5-fluorouracil and leucovorin in previously treated patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis | 1992 |
Induction chemotherapy with carboplatin and 5-fluorouracil in combination with radiotherapy in loco-regionally advanced epidermoid carcinoma of the anus--preliminary results.
Topics: Adult; Aged; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Middle Aged; Radiotherapy | 1992 |
5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platinum; Remission Induction | 1992 |
Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, High Pressure Liquid; Cisplatin; Drug Stability; Excipients; Fluorouracil; Leukemia P388; Mice; Mice, Inbred DBA; Organoplatinum Compounds; Serum Albumin; Time Factors | 1992 |
[Vestibulotoxic effects of the cytostatic drug carboplatin in patients with head and neck tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Neoplasm Staging; Neuronal Plasticity; Oropharyngeal Neoplasms; Vestibular Diseases; Vestibular Function Tests; Vestibular Nerve | 1992 |
Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Resistance; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1992 |
[Antineoplastic effectiveness and unwanted side effects of polychemotherapy of extensive oro- and hypopharyngeal cancers--results of a prospective therapy study with 5-FU/cisplatin versus 5-FU/carboplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Auditory Threshold; Bone Marrow; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Evoked Potentials, Auditory; Fluorouracil; Glomerular Filtration Rate; Humans; Hypopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies | 1992 |
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Death; Doxorubicin; Fluorouracil; Hematopoietic Stem Cells; Humans; Interleukin-1; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Nude; Recombinant Proteins; Spleen; Time Factors; Tumor Necrosis Factor-alpha | 1992 |
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins | 1991 |
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine | 1992 |
Continuous infusion of 5-fluorouracil in ovarian cancer patients refractory to cisplatin and carboplatin.
Topics: Adult; Carboplatin; Cisplatin; Drug Evaluation; Drug Resistance; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms | 1991 |
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluorouracil; Humans; Leucovorin; Premedication; Remission Induction; Stomach Neoplasms; Time Factors | 1991 |
Carboplatin, continuous infusion fluorouracil and mid-cycle high-dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Hellenic Co-operative Oncology Group Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiography; Radiotherapy Dosage; Remission Induction; Survival Analysis | 1991 |
[Initial results of adjuvant chemotherapy of operated cervix cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Neoplasm Staging; Neoplastic Cells, Circulating; Uterine Cervical Neoplasms | 1991 |
Neoadjuvant carboplatin & 5 fluorouracil combination chemotherapy and radiotherapy in the treatment of locally advanced head and neck cancer: primary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged | 1991 |
Continuous infusion of chemotherapy on an outpatient basis via a totally implanted venous access port.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Middle Aged; Mitoxantrone; Neoplasms; Self Administration | 1991 |
The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged 'in-use' conditions.
Topics: Carboplatin; Drug Stability; Drug Storage; Fluorouracil; Heroin; Infusion Pumps; Mitoxantrone; Temperature | 1991 |
[Intraperitoneal chemotherapy through implantable injection port in patients with advanced ovarian (or tubal) carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Picibanil | 1991 |
Cytotoxicity of cisplatin and carboplatin used alone and in combination with the other anticancer drugs in the mouse embryo C3H10T1/2 cell line.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cell Line; Cell Survival; Cisplatin; Drug Screening Assays, Antitumor; Fluorouracil; Methotrexate; Mice; Mice, Inbred C3H; Organoplatinum Compounds; Vincristine | 1988 |
[Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Fluorouracil; Humans; In Vitro Techniques; Organoplatinum Compounds; Pharyngeal Neoplasms; Tumor Cells, Cultured | 1989 |
Carboplatin and continuous infusion 5-fluorouracil for advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Stomatitis; Thrombocytopenia | 1989 |
Carboplatin. The better platinum in head and neck cancer?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood; Carboplatin; Cisplatin; Drug Evaluation; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney; Organoplatinum Compounds; Remission Induction | 1989 |
Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Evaluation; Fluorouracil; Humans; Mice; Neoplasms; Neoplasms, Experimental; Organoplatinum Compounds; Oxaliplatin; Papio | 1989 |
Intraperitoneal chemotherapy in peritoneal malignancy: impact of intensive system care on practicability.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Cisplatin; Critical Care; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies | 1989 |
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
Topics: Acetylglucosaminidase; Acute Disease; Adult; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD13 Antigens; Child; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney Diseases; Kidney Tubules; Neoplasms; Organoplatinum Compounds; Proteinuria; Saline Solution, Hypertonic | 1987 |
Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Fluorouracil; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neoplasm Transplantation; Organoplatinum Compounds | 1988 |
[Results of a phase II study with the new cytostatic drug carboplatin in combination with 5-fluorouracil in the primary treatment of advanced squamous cell cancers of the head and neck].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds | 1988 |
A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Hematologic Diseases; Humans; Male; Middle Aged; Organoplatinum Compounds | 1987 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Forecasting; Humans; In Vitro Techniques; Lymphatic Metastasis; Melanoma; Methotrexate; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction; Retrospective Studies; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1994 |
Palliative, intraarterial chemotherapy for advanced head and neck cancer using an implantable port system.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carotid Artery, External; Catheters, Indwelling; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Palliative Care | 1994 |
Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Marrow; Bone Marrow Cells; Carboplatin; Carmustine; Cell Adhesion Molecules; Cell Movement; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Fluorouracil; Gene Expression; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; L-Selectin; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Neutrophils; Platelet Count; Podophyllotoxin; Receptors, Very Late Antigen; Thiotepa | 1995 |
Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Glutathione; Glutathione Transferase; Humans; Laryngeal Neoplasms; Mitomycin; Proto-Oncogenes; Tumor Cells, Cultured; Vinblastine; Vincristine | 1995 |
Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Humans; Male; Urinary Bladder Neoplasms | 1994 |
Clonogenic survival studies of human colon tumor cell lines in vitro: combined hyperthermia, 5-fluorouracil/leucovorin, carboplatin and tumor necrosis factor.
Topics: Carboplatin; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Fluorouracil; Humans; Hyperthermia, Induced; Leucovorin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Stem Cell Assay | 1995 |
Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Parenteral; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Postoperative Complications; Reoperation; Retrospective Studies | 1994 |
Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens.
Topics: Carboplatin; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Drug Evaluation; Drug Stability; Drug Therapy, Combination; Esophageal Neoplasms; Fluorouracil; Heparin; Humans; Infusions, Intravenous; Temperature | 1994 |
[Combined treatment of radiotherapy, neo-adjuvant chemotherapy and adjuvant chemotherapy for nasopharyngeal carcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy, High-Energy | 1994 |
[The effect of induction chemotherapy with CBDCA, 5-FU and UFT in head and neck cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Tegafur; Uracil | 1994 |
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposide.
Topics: Animals; Ascitic Fluid; Carboplatin; Etoposide; Fluorouracil; Half-Life; Injections, Intraperitoneal; Lymph; Lymph Nodes; Peritoneum; Permeability; Swine | 1993 |
Carboplatin in patients with advanced colorectal cancer pretreated with fluoropyrimidines.
Topics: Adenocarcinoma; Adult; Aged; Carboplatin; Colonic Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Rectal Neoplasms; Salvage Therapy | 1993 |
[Intermittent intra-arterial infusion chemotherapy of 5-FU and carboplatin for unresectable liver metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1993 |
[A case of complete response by intermittent intra-arterial injection of 5-fluorouracil and carboplatin for liver metastases due to pancreatic cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Remission Induction | 1993 |
Combined chemotherapy and radiation for bulky stages I-II cervical cancer: comparison of concurrent and sequential regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Life Tables; Middle Aged; Radiation Injuries; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 1993 |
Carboplatin and 5-fluorouracil in advanced and recurrent squamous carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local | 1993 |
Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Epithelium; Female; Fluorouracil; Humans; Male; Prognosis; Urinary Bladder Neoplasms | 1993 |
Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro.
Topics: Adenocarcinoma; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Colonic Neoplasms; Combined Modality Therapy; Fever; Fluorouracil; Humans; Immunotherapy; Leucovorin; Linear Models; Logistic Models; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Surgical resection of pulmonary metastases from nasopharyngeal carcinoma.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Pneumonectomy; Postoperative Care; Time Factors | 1996 |
[Synergistic effects of tumor necrosis factor interferon-gamma and chemotherapeutic drugs on human ovarian cancer cell lines in vitro].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Division; Drug Synergism; Epirubicin; Female; Fluorouracil; Humans; Interferon-gamma; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |
Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Meta-Analysis as Topic; Methotrexate; Neoplasms; Ovarian Neoplasms; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design | 1996 |
[Two cases of multiple liver metastases (H3) from colon cancer treated by home hepatic arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Fluorouracil; Hepatic Artery; Home Care Services, Hospital-Based; Humans; Infusion Pumps, Implantable; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Quality of Life; Survival Analysis | 1995 |
[A case of colon cancer with local recurrence successfully treated by systemic and local intra-arterial chemotherapy using a combination of 5-fluorouracil, interferon-alpha 2A, leucovorin and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colectomy; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intra-Arterial; Injections, Intramuscular; Interferon alpha-2; Interferon-alpha; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins | 1997 |
Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Interactions; Etoposide; Fluorouracil; Mice; Mice, Inbred C3H; Paclitaxel; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1997 |
[Results of adjuvant chemotherapy of operated high risk cervix carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Uterine Cervical Neoplasms | 1996 |
[Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy | 1996 |
[A case report of tongue cancer presenting with SSD type brain embolism induced by chemotherapy with CBDCA and 5-FU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Intracranial Embolism and Thrombosis; Tomography, X-Ray Computed; Tongue Neoplasms | 1997 |
[Inoperable esophageal carcinoma managed by combined chemotherapy (CBDCA, 5-FU and VDS) and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheterization; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Radiotherapy Dosage; Survival Rate; Vindesine | 1997 |
[Therapy pf cervical lymph node metastases of unknown primary tumor].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vindesine | 1997 |
First line protracted venous infusion fluorouracil with CisDDP or carboplatine in advanced colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Cisplatin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged | 1997 |
[High-dosage chemotherapy and autologous transplant of hematopoietic germ cells from peripheral blood in high-risk recurrence carcinoma of the breast (with >= or 10 involved axillary nodes at diagnosis) Preliminary results of the Solti 9301 cooperative st
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous | 1997 |
[Percutanous trans-catheter intervention for the diagnosis and treatment of malignant pericardial effusion, with a report of 50 cases].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheterization; Catheters, Indwelling; Drainage; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Pericardial Effusion; Pericardium; Ultrasonography, Interventional | 1996 |
[Polarographic detection of reoxygenation of lymph node metastases in the initial phase of primary radio- and radiochemotherapy in patients with advanced squamous epithelial carcinomas of the head and neck].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Hypoxia; Combined Modality Therapy; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Oxygen Consumption; Polarography; Prognosis | 1997 |
Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Regression Analysis; Survival Rate; Time Factors; Urinary Bladder Neoplasms | 1998 |
[Importance of AUC of carboplatin in head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Retrospective Studies; Therapeutic Equivalency; Thrombocytopenia; Treatment Outcome | 1998 |
Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Remission Induction | 1998 |
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antineoplastic Agents; Carboplatin; Carrier Proteins; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; DNA Adducts; DNA Damage; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methylnitronitrosoguanidine; Mutagenesis; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Thioguanine; Tumor Cells, Cultured | 1997 |
Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration.
Topics: Animals; Antineoplastic Agents; Carboplatin; Etoposide; Fluorouracil; Injections, Intraperitoneal; Lymph; Peritoneum; Swine; Vasopressins | 1996 |
[Experience of cancer home chemotherapy with cooperation between hospital and clinic].
Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Home Care Services, Hospital-Based; Humans; Infusion Pumps, Implantable; Male; Neoplasms | 1998 |
Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Oxygen; Pilot Projects; Remission Induction; Survival Analysis; Treatment Outcome | 1999 |
A comparison of peripheral blood stem cell apheresis using the Fenwal CS3000 Plus and COBE Spectra.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Carboplatin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Hematocrit; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Mastectomy; Middle Aged; Thiotepa | 1995 |
Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; beta-Alanine; Biotransformation; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorine; Fluorouracil; Head and Neck Neoplasms; Humans; Isotopes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged | 1999 |
Preoperative combined radiotherapy and chemotherapy for rectal cancer does not affect early postoperative morbidity and mortality in low anterior resection.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Case-Control Studies; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Morbidity; Multivariate Analysis; Postoperative Complications; Preoperative Care; Radiotherapy, High-Energy; Rectal Neoplasms; Retrospective Studies; Risk Factors | 1999 |
[Clinical evaluation of weekly hepatic arterial infusion chemotherapy in patients with unresectable metastatic liver cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate | 1999 |
Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Staging; Retrospective Studies; Treatment Failure | 1999 |
[Changes in hemoglobin concentrations in combined radio- and chemotherapy in locally advanced ORL tumors].
Topics: Adult; Aged; Anemia; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Hemoglobins; Humans; Male; Middle Aged; Radiotherapy Dosage; Time Factors | 1999 |
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Time Factors; Vindesine | 1999 |
High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Metastasis; Middle Aged; Mitoxantrone; Neck; Retrospective Studies; Survival Rate; Tamoxifen | 2000 |
Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Prognosis; Radiation Tolerance; Survival Rate; Thymidine Phosphorylase | 2000 |
Primary lymphoepithelioma-like carcinoma of the lung.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Diagnosis, Differential; Fatal Outcome; Fluorouracil; Humans; Lung Neoplasms; Male; Tomography, X-Ray Computed | 2000 |
Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Cyclophosphamide; Docetaxel; Female; Fluorouracil; Folic Acid Antagonists; Glutamates; Guanine; Humans; Injections, Intraperitoneal; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pemetrexed; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine; Vinorelbine; Weight Loss | 2000 |
Antisense suppression of proline-directed protein kinase FA enhances chemosensitivity in human prostate cancer cells.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; DNA, Antisense; DNA, Complementary; DNA, Recombinant; Dose-Response Relationship, Drug; Fluorouracil; Gene Expression Regulation, Enzymologic; Genetic Vectors; Humans; Hydroxyurea; Male; Paclitaxel; Proline-Directed Protein Kinases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Transfection; Tumor Cells, Cultured | 2000 |
[Evaluation of a novel adjuvant chemotherapy for non-resectable advanced gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Gastrectomy; Humans; In Vitro Techniques; Male; Middle Aged; Stomach Neoplasms | 1997 |
Toxicity of anticancer agents mediated by electroporation in vitro.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Cell Membrane Permeability; Cisplatin; Electroporation; Fluorouracil; Humans; Paclitaxel; Tumor Cells, Cultured | 2000 |
Ovarian-cancer results cause a stir at cancer conference.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medical Oncology; Ovarian Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Taxoids | 2000 |
Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colorectal Neoplasms; Erythropoietin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms | 2000 |
Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Kidney Diseases; Korea; Life Tables; Lymphatic Metastasis; Middle Aged; Particle Accelerators; Radiotherapy, High-Energy; Retrospective Studies; Risk; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2000 |
5-FU multifocal inflammatory leukoencephalopathy and dihydropyrimidine dehydrogenase deficiency.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Oxidoreductases | 2001 |
Radiotherapy is an effective treatment for high-risk T1-bladder cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Data Interpretation, Statistical; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Factors; Salvage Therapy; Survival Analysis; Time Factors; Urinary Bladder Neoplasms | 2001 |
[Chemotherapy with cisplatinum, carboplatin and 5FU-folinic acid, followed by concomitant chemo-radiotherapy in unresectable esophageal carcinomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kidney; Leucovorin; Lymphopenia; Male; Middle Aged; Neutropenia; Prospective Studies; Survival Analysis; Thrombocytopenia | 2001 |
A preclinical model for experimental chemotherapy of human head and neck cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease Models, Animal; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Ifosfamide; Methotrexate; Mice; Mice, Nude; Paclitaxel; Survival Rate; Taxoids | 2001 |
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Centrifugation; Combined Modality Therapy; Cryoprotective Agents; Cyclophosphamide; Dimethyl Sulfoxide; Epirubicin; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Staging; Recombinant Proteins; Remission Induction; Treatment Outcome | 2001 |
Influence of chemotherapy on endosteal implant survival and success in oral cancer patients.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis, Implant-Supported; Dental Restoration Failure; Female; Fluorouracil; Follow-Up Studies; Humans; Life Tables; Male; Mandible; Middle Aged; Mouth Neoplasms; Osseointegration; Retrospective Studies; Statistics as Topic; Survival Analysis; Time Factors; Treatment Outcome | 2001 |
[Medical cost analysis of neoadjuvant chemotherapy for advanced tongue and oropharyngeal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost-Benefit Analysis; Female; Fluorouracil; Humans; Length of Stay; Male; Middle Aged; Neoadjuvant Therapy; Oropharyngeal Neoplasms; Quality of Life; Tongue Neoplasms | 2001 |
Larynx-preserving pharyngo-esophagectomy after chemoradiation in the treatment of cancer of the pharyngo-esophageal junction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Follow-Up Studies; Humans; Laryngectomy; Neoadjuvant Therapy; Pharyngeal Neoplasms; Pharyngectomy | 2001 |
[Combination therapy of patients with locally advanced breast cancer].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Mammography; Mastectomy, Radical; Middle Aged; Radiotherapy Dosage; Survival Analysis; Time Factors | 2001 |
High-dose adjuvant chemotherapy for patients with high-risk breast cancer: efficacy is still an open question.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Thiotepa | 2000 |
Concomitant chemoradiotherapy in pyriform sinus carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Larynx; Male; Middle Aged; Survival Rate | 2002 |
Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma; Cell Hypoxia; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Oxygen; Prognosis; Survival Analysis; Treatment Outcome | 2003 |
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Lymph Nodes; Male; Middle Aged; Paclitaxel; Quality of Life; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Outcome | 2003 |
[Apoptosis of human pancreatic carcinoma cell lines induced by combinations of chemotherapeutic drugs].
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Doxorubicin; Epirubicin; Fluorouracil; Humans; Mitomycin; Pancreatic Neoplasms; Tumor Cells, Cultured | 1999 |
Stage IVB uterine endometrial cancer successfully salvaged by chemoradiotherapy and surgery.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Endometrial Neoplasms; Female; Fluorouracil; Humans; Magnetic Resonance Imaging; Metaplasia; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy, Adjuvant; Salvage Therapy; Tomography, X-Ray Computed; Uterine Neoplasms; Uterus | 2003 |
Clear cell adenocarcinoma in a female urethral diverticulum.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Pelvic Exenteration; Radiography; Radiotherapy, Adjuvant; Urethral Neoplasms | 2003 |
In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents.
Topics: Acrylates; Antineoplastic Agents; Biocompatible Materials; Carboplatin; Chemical Phenomena; Chemistry, Physical; Chemoembolization, Therapeutic; Doxorubicin; Drug Carriers; Fluorouracil; Gelatin; In Vitro Techniques; Methylamines; Microspheres; Mitomycin | 2003 |
Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongue.
Topics: Anemia, Iron-Deficiency; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Celiac Disease; Deglutition Disorders; Drug Therapy, Combination; Esophageal Neoplasms; Female; Fluorouracil; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Plummer-Vinson Syndrome; Tongue Neoplasms | 2003 |
[Chronobiological considerations for the management of human head and neck cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case Management; Chronotherapy; Circadian Rhythm; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Treatment Outcome | 2003 |
Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Nucleus; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Ifosfamide; Male; Micronucleus Tests; Middle Aged; Mouth Mucosa | 2003 |
[Dynamic magnetic resonance tomography (dMRT). It's value in advanced head-neck tumors treated with radiochemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Contrast Media; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Oropharyngeal Neoplasms; Prognosis; Treatment Outcome | 2003 |
Adenoid cystic carcinoma of the lacrimal gland.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenoid Cystic; Child; Combined Modality Therapy; Eye Neoplasms; Female; Fluorouracil; Humans; Lacrimal Apparatus | 2003 |
Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Middle Aged; Quality Assurance, Health Care; Survival Rate; Thiotepa; Transplantation, Autologous | 2002 |
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Middle Aged; Paclitaxel; Quality of Life; Radiotherapy Dosage; Remission Induction; Survival Rate | 2003 |
Choroidal metastasis from adenocarcinoma of the esophagus.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choroid Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Fatal Outcome; Fluorescein Angiography; Fluorouracil; Humans; Leucovorin; Male; Middle Aged | 2003 |
Influence of FasL gene expression on hepatic metastasis of colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Cell Division; Cell Line, Tumor; Colorectal Neoplasms; DNA, Complementary; Drug Resistance, Neoplasm; Fas Ligand Protein; Female; Fluorouracil; Gene Expression; Humans; Liver Neoplasms; Male; Membrane Glycoproteins; Middle Aged; Transfection | 2004 |
Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs.
Topics: Aldehyde-Lyases; Animals; Carboplatin; Cell Death; Cell Enlargement; Cell Nucleus; Ceramides; Cisplatin; Cloning, Molecular; Dictyostelium; Doxorubicin; Enzyme Inhibitors; Fluorouracil; Mutation; Parasitic Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Sphingolipids; Sphingosine | 2004 |
Use of LeVeen pleuroperitoneal shunt for refractory high-volume chylothorax.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chylothorax; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagectomy; Fatal Outcome; Fluorouracil; Humans; Ligation; Male; Middle Aged; Neoplasm Metastasis; Parenteral Nutrition, Total; Peritoneovenous Shunt; Pleural Effusion; Postoperative Complications; Respiration, Artificial; Taxoids; Thoracostomy; Thoracotomy; Tissue Adhesives | 2004 |
[Experimental study of sensitivity to chemotherapeutic agents for human endometrial carcinoma cell line].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endometrial Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Organoplatinum Compounds; Oxaliplatin | 2004 |
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Survival Rate | 2004 |
The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fluorouracil; Humans; Inhibitory Concentration 50; Mouth Neoplasms; Paclitaxel; Predictive Value of Tests | 2004 |
Chemotherapy for recurrent or persistent cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Clinical Trials as Topic; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Salvage Therapy; Uterine Cervical Neoplasms | 2004 |
Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations.
Topics: 2-Methoxyestradiol; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Epirubicin; Estradiol; Female; Fluorouracil; Humans; Ovarian Neoplasms; Paclitaxel; Taxoids; Vinblastine; Vinorelbine | 2004 |
[Efficacy of selective continuous transarterial infusion chemotherapy on advanced pancreatic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Remission Induction; Survival Rate | 2004 |
Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chi-Square Distribution; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Logistic Models; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Proportional Hazards Models; Radiotherapy Dosage; Rectal Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Nucleus; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Ifosfamide; Male; Micronucleus Tests; Middle Aged; Mouth Mucosa | 2004 |
Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chronotherapy; Colorectal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Quality of Life | 2005 |
Post-operative adjuvant chemoradiotherapy with carboplatin and 5-fluorouracil for primary branchiogenic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Branchioma; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiotherapy, Adjuvant | 2005 |
DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carboplatin; Caspase 9; Caspases; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; KB Cells; Papillomaviridae; Papillomavirus Infections; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Transfection | 2006 |
Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Radiotherapy; Radiotherapy Dosage; Survival Analysis; Time Factors; Uterine Cervical Neoplasms | 2005 |
Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis.
Topics: Adenocarcinoma, Sebaceous; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Eyelid Neoplasms; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Orbital Neoplasms; Sebaceous Gland Neoplasms; Tomography, X-Ray Computed | 2005 |
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngoscopy; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Palliative Care; Radiation Dosage; Radiation Injuries; Remission Induction; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Osteoradionecrosis; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2005 |
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Carboplatin; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pilot Projects; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
Combination chemotherapy in advanced small bowel adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Survival Analysis; Treatment Outcome | 2005 |
Intraperitoneal chemotherapy in ovarian carcinoma with the combination of carboplatin and 5-fluorouracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Fluorouracil; Humans; Infusions, Parenteral; Ovarian Neoplasms; Treatment Outcome | 1989 |
[Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer].
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cisplatin; Docetaxel; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Infusions, Parenteral; Mice; Mice, Nude; Neoplasm Seeding; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Taxoids; Tegafur | 2005 |
[Combination therapy with TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Oxonic Acid; Pyridines; Taxoids; Tegafur | 2005 |
[Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
Topics: Adult; Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Female; Fluorouracil; Glomerular Filtration Rate; Head and Neck Neoplasms; Humans; Kidney; Kidney Function Tests; Male; Middle Aged | 2006 |
Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorouracil; Humans; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2006 |
[Improvement of postoperative radiotherapy in the complex treatment of stage II-III cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Methyl-beta-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-kappaB and Bcl-2.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; NF-kappa B; Oncogene Protein v-akt; Phosphorylation; Proto-Oncogene Proteins c-bcl-2 | 2006 |
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
Topics: Adult; Aged; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Calcium-Binding Proteins; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Epirubicin; Epithelial Cell Adhesion Molecule; Female; Fluorouracil; Follow-Up Studies; Humans; Keratins; Membrane Proteins; Middle Aged; Multivariate Analysis; Odds Ratio; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Predictive Value of Tests; Presenilin-2; Prognosis; Receptor, ErbB-2; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Risk Factors; RNA Precursors; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Thiotepa; Treatment Outcome | 2006 |
Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Retrospective Studies; Risk Factors; Uterine Cervical Neoplasms | 2007 |
HIV-associated anal squamous cell cancer: an otherwise preventable disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Colostomy; Fatal Outcome; Fluorouracil; HIV Infections; Homosexuality, Male; Humans; Laparotomy; Male; Middle Aged; Mitomycin; Paclitaxel; Palliative Care; Radiotherapy, Adjuvant | 2006 |
Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2006 |
[Chemotherapy guidance of the drug sensitivity test in vitro in human laryngeal squamous cell carcinoma].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Laryngeal Neoplasms; Paclitaxel | 2006 |
Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Prognosis; Radioisotope Teletherapy; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed | 2006 |
Gadd45alpha does not modulate the carboplatin or 5-fluorouracil-induced apoptosis in human papillomavirus-positive cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Carboplatin; Cell Cycle Proteins; Fluorescent Antibody Technique; Fluorouracil; HeLa Cells; Humans; Nuclear Proteins; Papillomaviridae; Papillomavirus Infections; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2007 |
Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carboplatin; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Leukemia L1210; Lung Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Splenic Diseases; Survival Rate; Weight Loss | 2006 |
A prospective investigation of chemotherapy-induced neutropenia and quality of life.
Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; Cisplatin; Cyclophosphamide; Depression; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Prednisone; Prospective Studies; Psychiatric Status Rating Scales; Psychometrics; Quality of Life; Regression Analysis; Severity of Illness Index; Sickness Impact Profile; Taxoids; Treatment Outcome; United States; Vincristine | 2006 |
[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Topics: Adult; Antineoplastic Agents; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms | 2007 |
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate | 2007 |
[Drug sensitivity test and drug-resistance gene assessment for chemotherapy planning for tumors derived from high-passage mouse gastric cancer cells: therapeutic effect observation in mice].
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Immunohistochemistry; Mice; Mitomycin; Neoplasm Transplantation; Stomach Neoplasms; Treatment Outcome; Tumor Burden | 2007 |
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate | 2007 |
Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy Dosage; Rectum; Survival Rate; Urinary Bladder; Uterine Cervical Neoplasms | 2007 |
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma; Cisplatin; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Vincristine | 2008 |
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2008 |
Combined systemic therapy and radiotherapy for bladder cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cystectomy; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Methotrexate; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Salvage Therapy; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2007 |
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Endosonography; Female; Fluorouracil; Gamma Rays; Humans; Leucovorin; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Rectal Neoplasms | 2008 |
A new method of selective intra-arterial infusion therapy via the superficial temporal artery for head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Antineoplastic Agents; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Organoplatinum Compounds; Radiography, Interventional; Radiotherapy, Adjuvant; Temporal Arteries; Tongue Neoplasms | 2008 |
Intra-arterial chemoradiotherapy for locally advanced oral cavity cancer: analysis of therapeutic results in 134 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Prognosis; Temporal Arteries | 2008 |
Treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Survival Rate; Taxoids | 2008 |
Treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Survival Analysis; Taxoids | 2008 |
Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chi-Square Distribution; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nutrition Assessment; Nutritional Status; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2008 |
Treatment results of continuous intra-arterial CBDCA infusion chemotherapy in combination with radiation therapy for locally advanced tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carotid Artery, External; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Tongue; Tongue Neoplasms | 2008 |
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Patient Selection; Proportional Hazards Models; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2008 |
Platinum-based chemotherapy in triple-negative breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Vinblastine | 2008 |
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Deoxycytidine; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Prognosis; Quality of Life; Survival Rate | 2008 |
Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tumor Burden | 2009 |
Effects of human growth hormone on haematopoietic recovery of rats receiving chemotherapy.
Topics: Animals; Body Weight; Bone Marrow Cells; Carboplatin; Fluorouracil; Hematopoietic System; Human Growth Hormone; Humans; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley | 2008 |
Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Predictive Value of Tests; Prognosis; Radiotherapy, Adjuvant; Retreatment; Retrospective Studies; Risk Factors; Stereotaxic Techniques; Survival Analysis; Treatment Outcome | 2008 |
XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; DNA-Binding Proteins; Epirubicin; Female; Fluorouracil; gamma-Glutamyl Hydrolase; Glutathione S-Transferase pi; Humans; Interferon-gamma; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Neoadjuvant Therapy; Paclitaxel; Polymorphism, Single Nucleotide; Retrospective Studies; Uterine Cervical Neoplasms; X-ray Repair Cross Complementing Protein 1 | 2008 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fluorouracil; Focal Nodular Hyperplasia; Granulocyte Colony-Stimulating Factor; Hepatectomy; Hepatoblastoma; Humans; Ifosfamide; Immunoglobulin G; Incidental Findings; Liver Neoplasms; Male; Melphalan; Mesna; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Vincristine | 2008 |
[Intra-arterial chemotherapy and chemoembolization in the combined treatment for locally advanced carcinoma of the head and neck].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoembolization, Therapeutic; Disease Progression; Female; Fluorouracil; Gelatin Sponge, Absorbable; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Genotoxic effects of wastewater from an oncological ward.
Topics: Animals; Carboplatin; Cells, Cultured; Cisplatin; Comet Assay; DNA Damage; Fluorouracil; Hospitals; Models, Theoretical; Rats; Waste Products | 2009 |
The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Maxillary Sinus; Methotrexate; Middle Aged; Neoadjuvant Therapy; Organ Preservation; Paranasal Sinus Neoplasms; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2009 |
Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Hypoxia; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Laryngeal Neoplasms; Middle Aged; Misonidazole; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Carboplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Fatal Outcome; Female; Fluorouracil; Hand; Humans; Lapatinib; Middle Aged; Onycholysis; Paclitaxel; Paresis; Peripheral Nervous System Diseases; Quinazolines; Taxoids; Trastuzumab; Vinblastine; Vinorelbine | 2009 |
Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Retrospective Studies; Tongue Neoplasms; Treatment Outcome | 2009 |
Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Metastasis at the site of a venous needle puncture in a patient with advanced cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Fatal Outcome; Female; Fluorouracil; Humans; Needles; Neoplasm Metastasis; Neoplastic Cells, Circulating; Paclitaxel; Punctures; Radiotherapy; Uterine Cervical Neoplasms | 2009 |
Clinical outcome of oropharyngeal carcinoma treated with platinum-based chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Fluorouracil; Humans; Japan; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oropharyngeal Neoplasms; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome | 2009 |
Treatment options in metastatic squamous cell carcinoma of the anal canal.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Humans; Incidence; Male; Mitomycin; Radiotherapy; Sexually Transmitted Diseases; United States | 2008 |
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cartilage; Cisplatin; Clinical Trials, Phase II as Topic; Disease-Free Survival; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Organ Preservation; Probability; Prognosis; Quality of Life; Radiography; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Tumor Burden | 2009 |
Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Endometrium; Epirubicin; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Menstrual Cycle; Middle Aged; Premenopause; Tamoxifen; Thiotepa; Ultrasonography | 2009 |
Cutaneous human papillomavirus in head and neck squamous cell carcinomas.
Topics: Aged; Alcohol Drinking; Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Transformation, Viral; Combined Modality Therapy; Disease-Free Survival; DNA Probes, HPV; DNA, Viral; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucous Membrane; Organ Specificity; Papillomavirus Infections; Prevalence; Risk Factors; Skin; Smoking | 2009 |
Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Middle Aged; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Taxoids; Tumor Burden | 2010 |
The prognostic value of TRAIL and its death receptors in cervical cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cytoplasm; Female; Fluorouracil; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Prognosis; Radiotherapy Dosage; Receptors, TNF-Related Apoptosis-Inducing Ligand; Tissue Array Analysis; TNF-Related Apoptosis-Inducing Ligand; Uterine Cervical Neoplasms; Young Adult | 2009 |
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Pulmonary Diffusing Capacity; Radiotherapy Dosage; Retrospective Studies | 2009 |
Intra-arterial infusion of chemotherapy in the treatment of penile cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Mitomycin; Penile Neoplasms; Remission Induction | 2009 |
Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carboplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Radiodermatitis; Radiotherapy, Adjuvant; Retrospective Studies | 2010 |
Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Apoptosis; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP40 Heat-Shock Proteins; Humans; Liver Neoplasms; Molecular Chaperones; Neoplasm Proteins; Quercetin; RNA Interference; RNA, Small Interfering; Transfection | 2009 |
Memoirs of differential radiation doses: Gemcitabine induced radiation recall.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gemcitabine; Humans; Mastectomy; Radiodermatitis; Radiotherapy; Radiotherapy Dosage | 2010 |
Docetaxel, carboplatin and 5-fluorouracil (TCF) chemotherapy in patients with unresectable metastatic carcinoma of cervix.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fluorouracil; Humans; Middle Aged; Retrospective Studies; Taxoids; Uterine Cervical Neoplasms | 2010 |
The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells.
Topics: Autophagy; Carboplatin; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Esophageal Neoplasms; Fluorouracil; Humans; Indoles; Osteosarcoma; Pyrroles; Signal Transduction | 2010 |
Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case report.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Female; Fluorouracil; Humans; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local | 2010 |
Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Enteral Nutrition; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Malnutrition; Middle Aged; Mucositis; Neoplasms, Squamous Cell; Patient Care Team; Radiodermatitis; Radiotherapy Dosage; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Stomatitis; Weight Loss | 2011 |
Chemoradiation for esophageal cancer: institutional experience with three different regimens.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Radiotherapy; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 2011 |
Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymphatic Irradiation; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors | 2011 |
Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Risk Factors; Survival Rate; Uterine Cervical Neoplasms | 2010 |
Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carboplatin; Cisplatin; Confidence Intervals; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Radiation Dosage; Radiotherapy, Intensity-Modulated; Rectum; Survival Rate; Treatment Outcome; Urinary Bladder; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine | 2011 |
Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.
Topics: Adult; Aged; Alcohol Oxidoreductases; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Breast Neoplasms; Capecitabine; Carboplatin; Case-Control Studies; Chromatography, Affinity; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Electrophoresis, Gel, Two-Dimensional; Female; Fluorouracil; Glutathione S-Transferase pi; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neurophysiology; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Phenotype; Survival Rate; Treatment Outcome | 2010 |
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Motor Neuron Disease; Neoplasm Staging; Neurophysiology; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Taxoids | 2010 |
Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2011 |
Sister Mary Joseph's nodule as a metastasis of ovarian adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Carboplatin; Colonoscopy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Neprilysin; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Receptors, Estrogen; Receptors, Progesterone; Sister Mary Joseph's Nodule; Skin Neoplasms; Treatment Outcome; Umbilicus; Vimentin; WT1 Proteins | 2010 |
Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Treatment Outcome | 2010 |
Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Femur Head; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Intestines; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder; Uterine Cervical Neoplasms | 2012 |
Combined chemoradiotherapy for early glottic cancer in clinical practice in Japan: analysis of 10 institutions.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Fluorouracil; Glottis; Humans; Japan; Laryngeal Neoplasms; Male; Middle Aged; Tegafur; Uracil | 2010 |
Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2012 |
The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Decision Making; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Neoplasm, Residual; Remission Induction; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2011 |
[Improvement of drug therapy for advanced gastric cancer used at a municipal clinical dispensary].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cancer Care Facilities; Carboplatin; Cisplatin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Russia; Stomach Neoplasms; Taxoids; Treatment Outcome | 2010 |
Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Case-Control Studies; Chemoradiotherapy; DNA; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Real-Time Polymerase Chain Reaction; Rectal Neoplasms; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Hyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells.
Topics: Acetylcysteine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Female; Fluorouracil; Glucose; Humans; Hyperglycemia; Inhibitory Concentration 50; NF-kappa B; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Verapamil | 2011 |
Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Middle Aged; Radioimmunotherapy; Radiotherapy; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome | 2011 |
Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Carboplatin; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Down-Regulation; Fluorouracil; Hep G2 Cells; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Purines; Quercetin; Roscovitine; Signal Transduction; Tumor Suppressor Protein p53 | 2011 |
20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
[Effectiveness of systemic chemotherapy of GEM+CBDCA+5-FU/LV and hepatic arterial infusion of CDDP in a case of advanced, combined hepatocellular-cholangiocarcinoma with multiple lung metastases].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carboplatin; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cisplatin; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Gemcitabine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male | 2011 |
Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Retrospective Studies; Salivary Gland Neoplasms | 2012 |
Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anticancer drugs in a human kidney cell nephrotoxicity model.
Topics: Animals; Antidotes; Antineoplastic Agents; Apoptosis; Biological Assay; Carboplatin; Cell Line; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Electric Impedance; Epithelial Cells; Fluorouracil; Glutathione; Humans; Kidney; Kidney Tubules; Thiosulfates | 2012 |
Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients in Northeast China.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; China; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids | 2011 |
Systemic chemotherapy using carboplatin and 5-fluorouracil for extrahepatic metastasis of hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Hepatocellular; Chi-Square Distribution; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.
Topics: Aged; Albumin-Bound Paclitaxel; Albumins; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Panitumumab; Papillomavirus Infections; Proportional Hazards Models; Radiation Tolerance; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids; Treatment Failure | 2012 |
Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Mastectomy; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Vinblastine; Vinorelbine | 2012 |
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Carboplatin; Confidence Intervals; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Female; Fluorouracil; Gemcitabine; Health Services Accessibility; Humans; Logistic Models; Lymphatic Metastasis; Medication Adherence; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Paclitaxel; Receptors, Estrogen; Switzerland; Taxoids; Vinblastine; Vinorelbine | 2012 |
The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Female; Fluorouracil; Half-Life; Humans; Lung Neoplasms; Mice; Mice, Nude; Mice, SCID; Paclitaxel; Receptors, Tumor Necrosis Factor; Stomach Neoplasms; Tumor Burden; TWEAK Receptor; Xenograft Model Antitumor Assays | 2012 |
Low morbidity after palliation of obstructing gastro-oesophageal adenocarcinoma to restore swallowing function.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Argon Plasma Coagulation; Capecitabine; Carboplatin; Chemoradiotherapy; Combined Modality Therapy; Deglutition Disorders; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Esophageal Perforation; Esophagogastric Junction; Female; Fluorouracil; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Prosthesis Failure; Retrospective Studies; Stents; Taxoids | 2012 |
Multi-institutional analysis of early glottic cancer from 2000 to 2005.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Glottis; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Taxoids; Tegafur; Time Factors; Uracil | 2012 |
Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2013 |
Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Risk of treatment related death and febrile neutropaenia with taxane-based adjuvant chemotherapy for breast cancer in a middle income country outside a clinical trial setting.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Carboplatin; Cause of Death; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Female; Fever; Fluorouracil; Humans; Malaysia; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Risk Factors; Taxoids | 2012 |
Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy; Breast Neoplasms; Capecitabine; Carboplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neovascularization, Pathologic; Paclitaxel; ROC Curve; Spectroscopy, Near-Infrared; Trastuzumab; Treatment Outcome; Ultrasonography, Interventional | 2013 |
[Esophageal cancer: outcome according to therapeutic strategy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Confidence Intervals; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Netherlands; Paclitaxel; Proportional Hazards Models; Radiotherapy Dosage; Survival Rate; Tumor Burden | 2013 |
[Therapeutic effects of sorafenib combined with transcatheter arterial chemoembolization and microwave ablation on postsurgical recurrent hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Remission Induction; Sorafenib; Survival Rate | 2012 |
Comparison of treatment compliance and nutritional outcomes among patients with nasopharyngeal carcinoma with and without percutaneous endoscopic gastrostomy during chemoradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Endoscopy, Gastrointestinal; Enteral Nutrition; Female; Fluorouracil; Gastrostomy; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Patient Compliance; Prognosis; Radiotherapy Dosage; Retrospective Studies; Weight Loss | 2012 |
Hypofractionated palliative radiotherapy for advanced head and neck cancer: the IHF2SQ regimen.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Palliative Care; Radiotherapy; Retrospective Studies; Sex Factors; Taxoids | 2013 |
Radiotherapy alone or combined with chemotherapy for the treatment of squamous cell carcinoma of the base of the tongue.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neck Dissection; Paclitaxel; Retrospective Studies; Tongue Neoplasms; Treatment Outcome | 2014 |
[Neuroendocrine tumors: analysis of 252 cases].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Cisplatin; Digestive System Neoplasms; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Retrospective Studies; Sex Factors; Survival Rate; Young Adult | 2013 |
Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2013 |
Treatment outcome of palliative chemotherapy in inoperable cholangiocarcinoma in Thailand.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Capecitabine; Carboplatin; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Prognosis; Retrospective Studies; Survival Rate | 2013 |
Predicting concentrations of the cytostatic drugs cyclophosphamide, carboplatin, 5-fluorouracil, and capecitabine throughout the sewage effluents and surface waters of Europe.
Topics: Capecitabine; Carboplatin; Cyclophosphamide; Cytostatic Agents; Deoxycytidine; Environmental Monitoring; Europe; Fluorouracil; Rivers; Sewage; Water Pollutants, Chemical | 2013 |
Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Pyridines; Radiotherapy Dosage; Retrospective Studies; Tegafur; Tongue Neoplasms; Treatment Outcome | 2013 |
Population-based comparison of two feeding tube approaches for head and neck cancer patients receiving concurrent systemic-radiation therapy: is a prophylactic feeding tube approach harmful or helpful?
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Female; Fluorouracil; Gastrostomy; Head and Neck Neoplasms; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Nutritional Support; Palliative Care; Weight Loss | 2013 |
Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids | 2014 |
Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Retrospective Studies; Sentinel Lymph Node Biopsy; Survival Rate; Tumor Burden; Ultrasonography; Vinblastine; Vinorelbine; Young Adult | 2013 |
Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Proportional Hazards Models; Retrospective Studies; Uterine Cervical Neoplasms | 2013 |
Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
Topics: Adenosine Triphosphatases; Animals; Annexin A4; Antineoplastic Agents; Biological Transport; Carboplatin; Cation Transport Proteins; Cell Line, Tumor; Cisplatin; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Fluorouracil; Humans; Mice; Mice, Inbred ICR; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2014 |
Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Glioblastoma; Humans; Leucovorin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Radiosurgery; Retrospective Studies; Treatment Outcome | 2014 |
[Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Taxoids; Treatment Outcome | 2014 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Genital Neoplasms, Male; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Retrospective Studies; Treatment Outcome; Vincristine; Vulvar Neoplasms | 2014 |
A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Tubulin Modulators | 2014 |
Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype.
Topics: Antineoplastic Agents; Autophagy; Carboplatin; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Furans; Glucose; Glycolysis; Humans; Hypoglycemia; Morpholines; Phenotype; Phosphatidylinositol 3-Kinases; Pyridines; Pyrimidines; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases | 2014 |
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Factors affecting outcomes of alternating chemoradiotherapy for nasopharyngeal cancer.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome | 2014 |
Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carboplatin; Carcinogenesis; Carcinoma, Ovarian Epithelial; Cell Culture Techniques; Cell Line, Tumor; Cell Shape; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms | 2014 |
Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Cyclin-Dependent Kinase Inhibitor p16; Disease-Free Survival; ErbB Receptors; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Otorhinolaryngologic Neoplasms; PTEN Phosphohydrolase; Retrospective Studies; Survival Rate | 2015 |
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carboplatin; Comparative Genomic Hybridization; Cyclophosphamide; DNA Breaks, Double-Stranded; DNA Repair; Epirubicin; Female; Fluorouracil; Homologous Recombination; Humans; Middle Aged; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Thiotepa; Treatment Outcome; Triple Negative Breast Neoplasms | 2014 |
[18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2015 |
Intraarterial chemotherapy as the first-line therapy in penile cancer.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Fluorouracil; Humans; Infusions, Intra-Arterial; Inguinal Canal; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Penile Neoplasms; Retrospective Studies | 2014 |
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Capecitabine; Carboplatin; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Treatment Outcome | 2014 |
Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC).
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Radiotherapy, Intensity-Modulated | 2014 |
Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Neoplasms; Postoperative Period; Prognosis; Rectal Neoplasms; Remission Induction; Survival Rate | 2015 |
Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Topics: AC133 Antigen; Animals; Antigens, CD; Carboplatin; Carcinogenesis; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Laryngeal Neoplasms; Mice; Neoplastic Stem Cells; Peptides; Polycomb Repressive Complex 1; Taxoids | 2015 |
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Mammaplasty; Mastectomy, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Perforator Flap; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Young Adult | 2015 |
Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Invasiveness; Organ Sparing Treatments; Peplomycin; Prognosis; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms | 2015 |
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Palliative Care; Polyurethanes; Retrospective Studies; Treatment Outcome | 2014 |
Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Chemoradiotherapy; Deglutition Disorders; Enteral Nutrition; Epidemiologic Methods; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Models, Theoretical; Organ Sparing Treatments; Radiometry; Radiotherapy, Intensity-Modulated; Young Adult | 2014 |
Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Camptothecin; Capecitabine; Carboplatin; Deoxycytidine; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Humans; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Receptor, ErbB-2; Retrospective Studies; Stomach Neoplasms; Trastuzumab | 2014 |
Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagoscopy; Female; Fluorouracil; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Remission Induction; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Tumor Burden | 2014 |
Treatment of invasive squamous cell carcinomas in an open Clagett window.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Debridement; Empyema; Female; Fluorouracil; Humans; Neoplasm Invasiveness; Paclitaxel; Pleural Cavity; Pleural Neoplasms; Thoracostomy | 2015 |
Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus.
Topics: Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Doxorubicin; Fluorouracil; Granulocyte-Macrophage Progenitor Cells; Male; Mice; Mice, Inbred C57BL; Neutropenia; Obesity; Thionucleotides; Uridine Monophosphate | 2015 |
[Recurrence sites following definitive intensity-modulated conformational radiotherapy of squamous-cell carcinomas of the upper aerodigestive tract].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids | 2015 |
Predictive role of neutrophil gelatinase-associated lipocalin in early diagnosis of platin-induced renal injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Carboplatin; Cisplatin; Creatinine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Lipocalin-2; Lipocalins; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Proto-Oncogene Proteins; Taxoids | 2015 |
Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Endoscopy; Ethmoid Sinus; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Organoplatinum Compounds; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Estrogens; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Progesterone; Prognosis; Proportional Hazards Models; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Triple Negative Breast Neoplasms; Vinblastine; Vinorelbine | 2015 |
Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Topics: Adult; Aldehyde Dehydrogenase 1 Family; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Immunoenzyme Techniques; Isoenzymes; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retinal Dehydrogenase; Survival Rate; Uterine Cervical Neoplasms | 2016 |
Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Leucovorin; Male; Middle Aged; Palliative Care; Remission Induction; Retrospective Studies; Taxoids; Treatment Outcome | 2015 |
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Paclitaxel; Perioperative Care; Retrospective Studies; Urethra; Urethral Neoplasms; Urinary Diversion | 2015 |
Mammographic breast density: Predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Density; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Mammary Glands, Human; Mammography; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome | 2015 |
Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Cisplatin; Cohort Studies; Diabetes Mellitus, Type 2; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Hypoglycemic Agents; Logistic Models; Male; Metformin; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
Treatment of T3 laryngeal cancer in the Netherlands: a national survey.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carboplatin; Carcinoma; Cetuximab; Cisplatin; Combined Modality Therapy; Disease Management; Dose Fractionation, Radiation; Fluorouracil; Guideline Adherence; Health Care Surveys; Humans; Laryngeal Neoplasms; Laryngectomy; Neoplasm Invasiveness; Neoplasm Staging; Netherlands; Organ Sparing Treatments; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiotherapy Planning, Computer-Assisted; Surveys and Questionnaires | 2015 |
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Capecitabine; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Pelvis; Radiation Injuries; Radiodermatitis; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; Tumor Burden | 2017 |
Olfaction in chemotherapy for head and neck malignancies.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Controlled Before-After Studies; Differential Threshold; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Olfaction Disorders; Pharyngeal Neoplasms; Prospective Studies; Sensory Thresholds; Smoking; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2016 |
Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Comorbidity; Female; Fluorouracil; Humans; Middle Aged; Neoplasms, Second Primary; Radiotherapy; Registries; Taiwan; Uterine Cervical Neoplasms; Young Adult | 2015 |
Survival Outcomes of Advanced and Recurrent Cervical Cancer Patients Treated with Chemotherapy: Experience of Northern Tertiary Care Hospital in Thailand.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Tertiary Care Centers; Thailand; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Concomitant External-beam Irradiation and Chemotherapy Followed by High-dose Rate Brachytherapy Boost in the Treatment of Squamous Cell Carcinoma of the Vagina: A Single-Center Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Retrospective Studies; Vaginal Neoplasms | 2016 |
Induction chemotherapy before surgery for unresectable head and neck cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Cohort Studies; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Paclitaxel; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome | 2016 |
Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Renal Insufficiency; Retrospective Studies; Salvage Therapy; Skin Neoplasms | 2016 |
Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Postoperative Complications; Radiotherapy, Conformal; Retrospective Studies; Time Factors; Treatment Outcome | 2016 |
ERCC1 Expression Can Predict Response to Platinum-Based Induction Chemotherapy in Head and Neck Cancer Cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Real-Time Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids | 2016 |
Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oropharyngeal Neoplasms; Radiodermatitis; Radiotherapy, Intensity-Modulated; Treatment Outcome; Xerostomia | 2016 |
Platinum based radiochemotherapies: Free radical mechanisms and radiotherapy sensitizers.
Topics: Antineoplastic Agents; Carboplatin; Chemoradiotherapy; Cisplatin; DNA Adducts; DNA Damage; Drug Synergism; Electrons; Fluorouracil; Free Radicals; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Oxidation-Reduction; Radiation-Sensitizing Agents | 2016 |
Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorouracil; Gemcitabine; Herpesvirus 4, Human; Humans; Leukocyte Count; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutrophils; Prognosis; Proportional Hazards Models; Radiotherapy; Randomized Controlled Trials as Topic; Singapore; Survival Rate | 2016 |
Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Endometriosis; Female; Fluorouracil; Humans; Hysterectomy; Logistic Models; Middle Aged; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prognosis; Retrospective Studies; Salpingectomy; Survival Rate | 2016 |
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cytokines; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Interleukin-1beta; Interleukin-6; Laryngeal Neoplasms; Mouth Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Saliva; Severity of Illness Index; Stomatitis; Taxoids; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paclitaxel; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids; Treatment Outcome; Young Adult | 2017 |
The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Paclitaxel; Prognosis; Proportional Hazards Models; Retrospective Studies | 2017 |
Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Fluorouracil; France; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2017 |
Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome | 2017 |
A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Patient Readmission; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Young Adult | 2017 |
Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies.
Topics: Animals; Apoptosis; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Fluorouracil; Humans; Mice; Mouth Neoplasms; NADPH Oxidases; Organoplatinum Compounds; Oxaliplatin; Platinum Compounds; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer.
Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cetuximab; DNA Mutational Analysis; Docetaxel; ErbB Receptors; Everolimus; Fluorouracil; Gene Expression; Head and Neck Neoplasms; High-Throughput Nucleotide Sequencing; Humans; Mice; Mice, Inbred NOD; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Xenograft Model Antitumor Assays | 2017 |
[Subacute cutaneous lupus erythematosus induced by 5-fluorouracil].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Substitution; Esophageal Neoplasms; Fluorouracil; Humans; Lung Neoplasms; Lupus Erythematosus, Cutaneous; Lymphatic Metastasis; Male; Middle Aged; Radiation Tolerance; Radiotherapy, Adjuvant; Ribonucleoproteins | 2017 |
Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome | 2018 |
Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel | 2017 |
HPV-related squamous cell carcinoma in a neovagina after male-to-female gender confirmation surgery.
Topics: Biopsy; Carboplatin; Carcinoma, Squamous Cell; Colostomy; Fatal Outcome; Female; Fluorouracil; Human papillomavirus 16; Humans; Magnetic Resonance Imaging; Male; Papillomavirus Infections; Sex Reassignment Surgery; Sigmoid Neoplasms; Transgender Persons | 2018 |
Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Radiotherapy; Treatment Outcome; Uterine Cervical Neoplasms; Vagina | 2017 |
ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma; Cisplatin; DNA-Binding Proteins; Endonucleases; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pelvic Neoplasms; Retrospective Studies; Survival Analysis; Topotecan; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
Important exposure controls for protection against antineoplastic agents: Highlights for oncology health care workers.
Topics: Adult; Antineoplastic Agents; Carboplatin; Cross-Sectional Studies; Cyclophosphamide; Female; Fluorouracil; Guideline Adherence; Health Personnel; Humans; Ifosfamide; Male; Occupational Exposure; Occupational Health; Oncology Service, Hospital; Personal Protective Equipment; Safety Management; Surveys and Questionnaires; Workforce | 2018 |
Investigation of cancer-associated fibroblasts and p62 expression in oral cancer before and after chemotherapy.
Topics: Actins; Antineoplastic Agents; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Female; Fibroblasts; Fluorouracil; Gene Expression; Humans; Male; Middle Aged; Mouth Neoplasms; RNA-Binding Proteins | 2018 |
Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tertiary Care Centers | 2018 |
Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Carboplatin; Cell Proliferation; Clinical Trials, Phase III as Topic; Cyclophosphamide; Docetaxel; Drug Screening Assays, Antitumor; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Receptor, ErbB-2; Retrospective Studies; Survival Analysis; Trastuzumab; Young Adult | 2018 |
Percutaneous nerve electrical stimulation for fatigue caused by chemotherapy for cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fatigue; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Retrospective Studies; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Proto-Oncogene Proteins p21(ras); Retrospective Studies | 2019 |
Towards risk-stratified induction regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Paclitaxel; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome | 2019 |
Ten-year outcome of curative "exclusive" chemotherapy in N0M0 squamous cell carcinoma of the larynx and pharynx with complete clinical response.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Salvage Therapy | 2019 |
The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cohort Studies; Female; Fluorouracil; Humans; Male; Neoplasm Metastasis; Oropharyngeal Neoplasms; Papillomavirus Infections; Retrospective Studies | 2019 |
Clinical outcomes of platinum-based chemotherapy plus cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck: comparison between platinum-sensitive and platinum-resistant patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Cohort Studies; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2019 |
Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2019 |
Advanced extramammary Paget disease treated with neoadjuvant chemotherapy: A report of two cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Fluorouracil; Groin; Humans; Lymph Node Excision; Male; Mitomycin; Neoadjuvant Therapy; Paget Disease, Extramammary; Skin Neoplasms; Vincristine | 2020 |
Crinamine Induces Apoptosis and Inhibits Proliferation, Migration, and Angiogenesis in Cervical Cancer SiHa Cells.
Topics: Amaryllidaceae Alkaloids; Angiogenesis Inhibitors; Animals; Carboplatin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Crinum; Disease Models, Animal; Embryo, Nonmammalian; Epithelial-Mesenchymal Transition; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Plant Extracts; Pyridines; Snail Family Transcription Factors; Uterine Cervical Neoplasms; Vimentin; Zebrafish | 2019 |
Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Progression-Free Survival; Radiotherapy; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Skin Neoplasms; Survival Rate; Treatment Outcome | 2020 |
lncRNA
Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Down-Regulation; Drug Resistance, Multiple; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Retinoblastoma; RNA, Long Noncoding; Vincristine | 2020 |
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate | 2020 |
Prophylactic piperacillin administration in pediatric patients with solid tumors following different intensities of chemotherapy.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Resistance, Microbial; Female; Fever; Fluorouracil; Humans; Infant; Leucovorin; Male; Methotrexate; Neuroblastoma; Neutropenia; Piperacillin; Retrospective Studies | 2020 |
Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy-a retrospective analysis of a register-based patient cohort.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Oxaliplatin; Palliative Care; Registries; Retrospective Studies; Stomach Neoplasms; Survival Analysis | 2020 |
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Paclitaxel; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2020 |
Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC): A Propensity Score-matched Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Propensity Score; Retrospective Studies | 2020 |
How to Choose the Right Treatment for Patients With Advanced Squamous Cell Carcinoma in the Absence of a Comparative Randomized Clinical Trial.
Topics: Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Fluorouracil; Humans; Paclitaxel | 2020 |
Reply to S. Kim et al.
Topics: Anus Neoplasms; Carboplatin; Cisplatin; Fluorouracil; Humans; Paclitaxel | 2020 |
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Stomach Neoplasms | 2021 |
CCDC167 as a potential therapeutic target and regulator of cell cycle-related networks in breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Carboplatin; Cell Cycle; Cell Proliferation; Doxorubicin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MCF-7 Cells; Paclitaxel; RNA, Messenger | 2021 |
The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cohort Studies; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Retrospective Studies; Survival Rate | 2021 |
Survival predictors and outcomes of patients with recurrent and/or metastatic head and neck cancer treated with chemotherapy plus cetuximab as first-line therapy: A real-world retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Drug Eruptions; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2021 |
Induction Chemotherapy Followed by either Chemoradiotherapy or Bioradiotherapy in Laryngeal Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Prognosis; Survival Rate | 2021 |
Anacardic Acids from
Topics: Anacardiaceae; Anacardic Acids; Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Carboplatin; Cell Line, Tumor; Cell Survival; Cytoprotection; Disease Models, Animal; Female; Fluorouracil; Hexanes; Leukocytes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Plant Bark | 2021 |
Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5-fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real-world evidence.
Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Chemoradiotherapy; Cisplatin; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Survival Rate; Taiwan | 2021 |
Laser Therapy as a Preventive Approach for Oral Mucositis in Cancer Patients Undergoing Chemotherapy: The Potential Role of Superoxide Dismutase.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Low-Level Light Therapy; Male; Middle Aged; Neoplasms; Oxidative Stress; Paclitaxel; Stomatitis; Superoxide Dismutase | 2021 |
Pre-operative Carboplatin/Paclitaxel
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Esophageal Neoplasms; Fluorouracil; Humans; Paclitaxel; Retrospective Studies | 2022 |
[A Case of Pancreas Neuroendocrine Carcinoma Achieved Long-Term Survival by Carboplatin plus Etoposide Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Fluorouracil; Humans; Male; Pancreas; Pancreatic Neoplasms | 2021 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cost-Benefit Analysis; Delivery of Health Care; Esophageal Neoplasms; Fluorouracil; Humans; Paclitaxel; Platinum; Quality-Adjusted Life Years; Trastuzumab | 2022 |
Chemoradiation for elderly patients (≥ 65 years) with esophageal cancer: a retrospective single-center analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Esophageal Neoplasms; Fluorouracil; Humans; Paclitaxel; Retrospective Studies | 2022 |
Primary Squamous Cell Carcinoma of the Liver with Good Response to Carboplatin and 5-Flurouracil: A Case Report.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Liver; Middle Aged; Neoplasm Recurrence, Local; Young Adult | 2022 |
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Topics: Carboplatin; Cetuximab; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Platinum; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Radical Resection of Locally Advanced Chest Wall cSCC With Muscle Flap Reconstruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Humans; Muscles; Paclitaxel; Skin Neoplasms; Thoracic Wall | 2023 |
Efficacy of chemotherapies for unresectable extramammary Paget disease: a single-centre retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Fluorouracil; Humans; Paget Disease, Extramammary; Retrospective Studies | 2023 |